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Abstract  
This master thesis explored the potential of staging moving bed biofilm reactor (MBBR) 
to achieve increased removal efficiencies of conventional and xenobiotic trace 
pollutants, as compared to single-staged systems. The project investigated the 
operation of a laboratory-scale anoxic staged MBBR system in continuous and in batch 
operation modes. Through comparison with a unstaged MBBR system, operating in 
parallel to the staged one, we aimed at understand whether the rate of heterotrophic 
denitrification increased in the staged system and what caused higher performances. 
Special attention was given to pharmaceuticals as xenobiotic organic pollutants, since 
much is still unknown about their fate and their hazardous effects on the environment. 
Several investigations confirmed the presence in the aquatic environment of different 
active compounds and among others pharmaceuticals and their metabolites. Most of 
the pharmaceuticals in the environment are not readily degradable and prone to bio-
accumulation. However for the majority of them, the fate and the environmental 
effects are still largely unknown. Where little evidence exists, medications have been 
demonstrated to influence gradual or indirect changes in the aquatic ecosystems. 
Nevertheless they are not yet targeted as prior pollutants by international 
environmental protective agencies. 
Presently, the improper disposal and the excretion by urines and faeces are the most 
significant causes of environmental contamination. With regard to the latter, 
traditional biological WWTPs are unable to efficiently remove pharmaceuticals from 
wastewater, thereby representing the most relevant source of pollution for the 
receiving water and soil bodies. So far the most effective strategy to address the 
problem is the further optimization of wastewater treatment processes. Degradation 
of pharmaceuticals in WWTPs depends primarily on the biological treatment step. The 
applied technologies and the design of bioreactors are the factors affecting the most 
the overall removal performance. 
In this study we investigated denitrification on moving bed biofilm reactors (MBBR). 
Biofilm reactors show very similar performances to the traditional activated sludge 
systems, but it also display additional advantages (i.e. no final sludge separation, 
biomass further specialization and less space demanding plants). High denitrification 
rates in MBBR have already been shown, but more effective configurations still have to 
be investigated. Regarding to this, reactor staging of activate sludge system have been 
demonstrated as effective solution. The purpose of this project is to assess the 
potential of MBBR staging for the removal of conventional (i.e. nitrate) and trace 
organic pollutants (i.e. pharmaceuticals) from municipal wastewater. In the staged 
configuration bacteria adapt to the specific conditions in each reactor and primarily to 
the available substrate. In this way, XOCs may potentially be a relevant carbon/energy 
source in the last reactor and bacteria may specialize to use them as substrate. This 
adaptation is supposed as the most probable reason for potential higher 
performances.  
By a continuous flow experiment and four batch experiments after an adaptation 
period, we aim to assess and compare a 3-staged MBBR to an unstaged MBBR using 
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real municipal wastewater as feed. Despite of conventional pollutants (COD, nitrates 
and nitrites) we assess and compare the removal of eight representative 
pharmaceuticals (atenolol, propranolol, metoprolol, diclofenac, carbamazepine, 
thrimetoprim, sulphametoxazole and venlafaxine).  
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1 Introduction  
The occurrence of active xenobiotic organic compounds (XOCs) in aquatic systems is an 
emerging issue. Several studies already detected the presence of active compounds 
and among others pharmaceuticals and their metabolites (Heberer T., 2002). The term 
pharmaceutical refers to prescription human drugs, non-prescription human drugs, 
illegal drugs and drugs metabolites. Together with personal care products, these 
compounds are collectively known as PPCPs (Pharmaceuticals and Personal Care 
Products).  
PPCPs are persistent compounds, this property affects the human metabolic pathway  
and ensure substances to express their curing effect (Halling-Sørensen B., 1997) 
(Sterner O., 2010). After administration, pharmaceuticals are fully or partially 
metabolized, being excreted in the form of Phase I, Phase II metabolites (i.e., 
conjugates) or in parent form (Sterner O., 2010). Many pharmaceuticals in the 
environment are not readily degradable (Halling-Sørensen B., 1997) and prone to bio-
accumulation (Sterner O., 2010). The fate and the effects on the environments and 
human health are still largely unknown (Halling-Sørensen B., 1997) (Dana W. Kolpin, 
2004). Where little evidence exists, medications have been demonstrated to influence 
gradual or indirect changes in the aquatic ecosystems (Kaplan S., 2013); Despite of 
being potentially harmful for the environment, they are not yet targeted as prior 
pollutants by international environmental protective agencies. 
Presently, the improper disposal and the excretion by urines and faeces are the most 
significant causes of water contamination. With regard to the latter, traditional 
biological WWTPs are unable to efficiently remove pharmaceuticals from wastewater, 
thereby representing the most relevant source of potential harmful impact on the 
environment (Kaplan S., 2013) (Ternes T.A. and Joss A., 2006) (Plosz et al., 2009). As 
results, pharmaceuticals tend to accumulate in environmental compartments, 
particularly receiving water and soil bodies (Daughton, 1999) (Heberer T., 2002).  
In the absence of scientific consensus, the “precautionary approach” suggests that any 
possible strategy to prevent environmental contamination and to remediate 
contamination should be enforced. Several options have been so far suggested to 
address this problem. Considering that pharmaceuticals consumption and discharge in 
the environment will not decrease in the next years, the most consistent and effective 
strategy is the optimization of wastewater treatment processes (Kaplan S., 2013).  
Degradation of pharmaceuticals in WWTPs depends primarily on the biological 
treatment step (Zorita S. et al., 2009). Applied treatment technologies and design of 
bioreactors are the factors affecting the most the overall removal performance (Falas 
P. et al., 2012). Parallel investigations on biofilm reactors and on the activated sludge 
processes showed comparable removal of a number of pharmaceuticals. Furthermore, 
biofilm processes display a number of additional advantages, such as: no final sludge 
separation, biomass further specialization and less space demanding plants (Gobel A., 
2007) (Falas P. et al., 2012) (Odengaard H., 1994).  
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Based on this, the interest in biofilm reactors increased considerably in the last decade, 
particularly in moving bed biofilm reactor (MBBR). MBBR has established itself as a 
robust, compact and flexible reactor (Odenaard, 2006). Even if it was developed for the 
nitrification process (Rusten B., 2005), today it is applied also for denitrification and 
high denitrification rates have been shown (Odenaard, 2006).  
On the other hand the processes themselves can also be improved significatively. For 
example the potential for further optimization of biological kinetics in activated sludge 
reactors has been demonstrated by means of bioreactor staging (Grady Jr. et al., 
Biological wastewater treatment, 1999) (Plosz B. et al., 2003). In staged systems, the 
bacterial population further specialize to the specific conditions in each “subreactor”, 
mainly the substrates availability, and eventually the consumption of more recalcitrant 
compounds becomes possible (Sean E. Scuras et al., 2001). There are direct evidences 
that high-biodiversity communities take grater advantages of the multiple niche 
opportunities and diverse systems capture a greater proportion of biologically available 
resources (Bradley J. Cardinale, 2011). 
1.1 Denitrification 
Complete denitrification is the bio-reduction of nitrogen oxidized species to nitrogen 
gas (N2). In absence of oxygen, nitrate (NO3
-) and nitrite (NO2
-) are the most common 
electron acceptors (Knowles, R., 1982) (Madigan M. T. and Martinko J.M., 1970) and by 
complete denitrification they are reduced to nitric oxide (NO), to nitrous oxide (N2O) 
and finally to N2. 
   
     
                     
Organisms capable of denitrification include fungi, archaea and bacteria (M.B.Allen 
and C.B. van Niel, 1952) (W.G. Zumft, 1997), the latter being the most common and 
widespread (Knowles, R., 1982). Denitrifying bacteria are biochemically and 
taxonomically very diverse (Knowles, R., 1982) In an anoxic reactor on a pre-
denitrification configuration, considering that no dosing of external carbon (methanol, 
ethanol) occurs,  the only organic substrate available is the biodegradable fraction 
naturally occurring in the wastewater. U.S. EPA (1993) estimated the average 
composition of the biodegradable fraction in wastewater and the following 
stoichiometric relation describes the complete reductive process: 
               
                         
  
    
                   . 
According to the previous half reaction, considering the heterotrophic yield (YH), i.e. 
the amount of biomass grown per amount of substrate degraded, and the grams of 
COD per electron equivalent (8 gCOD) the following ratio estimates the amount of COD 
to reduce completely 1 mg of NO3-N by heterotrophic denitrification: 
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The electrons from the degraded biodegradable fraction are transferred through the 
respiration chain and each step is catalyzed by a specific enzyme. Thus the synthesis 
and the expression of these enzymes regulate the entire process. The synthesis of 
denitrification enzymes depends mostly on the environmental conditions affecting the 
ecological niche (i.e. dissolved oxygen—DO, pH, COD/NO3-N). The more these 
conditions deviate from the optimum the more the complete denitrification is inhibited 
and the inhibition eventually results into the accumulation of intermediates (Y.C.Chiu, 
M.S.Chung, 2003). 
The first step in the respiration chain is catalyzed by the membrane-bound nitrate 
reductase (Nar). Some bacteria (i.e. Escherichia Coli) are capable to reduce nitrate to 
nitrite but not to complete the whole denitrification (M.B.Allen and C.B. van Niel, 1952) 
and are not considered as denitrifiers. Nitrite reductase (Nir) catalyzes the reduction of 
nitrite to the first gaseous products, i.e. nitric oxide (NO). Since all the bacteria involved 
in the N-cycle carry out the reduction of nitrite to nitric oxide, this is the most 
important step.  Consequently Nir is a key enzyme in the process (W.G. Zumft, 1997) (F. 
Schreiber, PP. Wundelin, K.M. Udert and G. F. Wells, 2012) and furthermore it is a good 
biomarker to investigate the community of denitrifiers (Boll M., 2004). There are two 
types of nitrite reductase, which  differ in terms of structure and metal content (W.G. 
Zumft, 1997). The first one (NirS) contains hemoproteins while the second copper 
(nirK) and their distributions have been studied by the detection of the genes  and 
(W.G. Zumft, 1997). Normally nitrite is reduced to nitric oxide. The reduction of nitric 
oxide to nitrous oxide is catalyzed by nitric oxide reductase (Nor) (W.G. Zumft, 1997) 
Most of denitrifying bacteria possess the gene encoding for this enzyme (F. Schreiber, 
PP. Wundelin, K.M. Udert and G. F. Wells, 2012). The last step is the nitrous oxide 
respiration (N2O), it is mediated by nitrous oxide reductase (N2Or) (W.G. Zumft, 1997). 
The majority of denitrifiers have the genes to encode all the enzymes but some of 
them lack the N2Or (W.G. Zumft, 1997). Since this enzyme can be easily repressed in 
case of inhibiting environmental conditions, the process may result in the accumulation 
of nitrous oxide as final product. Since the enzymes involved in the last steps are the 
most sensitive, “incomplete” denitrification  may result in significant emissions of nitric 
oxide and nitrous oxide. Importantly, nitrous oxide is a very strong greenhouse (GWP = 
300) gas and recently it became reason of concern in wastewater treatment plant 
design and management (W.G. Zumft, 1997).  The number of studies investigating the 
factors influencing nitrous oxide emissions has significantly increased in the last 5 years 
(M.J. Kampschreur, H. Temmink, R. Kleerebezem, m.S.M. Jetten and M. C.M. 
Loosdrecht, 2009). 
Factors influencing denitrification and nitrous oxide emission 
The most important factors controlling the heterotrophic denitrification in WWTP are 
(vit Mateju et al., 1992) (G. Tchobanoglous, F. L. Burton and H.D. Stensel, 2003) 
(K.L.Thomas, D. Lloyd and L. Boddy, 1994): 
 DO concentration; ; 
 pH; 
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 COD/ NO3-N  ratio.  
The presence of oxygen represses differently the action and the synthesis of the 
enzymes in the complete denitrification (Knowles, R., 1982) (K.L.Thomas, D. Lloyd and 
L. Boddy, 1994). The sensitivity to oxygen concentration is also variable among the 
denitrifying species (K.L.Thomas, D. Lloyd and L. Boddy, 1994). On the other hand some 
bacteria (Azospirillum brasilense, Pseudomonas denitrificans, Thauera denitrificans) 
synthetize Nar, but not Nir, also at low concentration of oxygen (vit Mateju et al., 
1992). Denitrification in presence of oxygen is termed “aerobic denitrification” or “co-
respiration” of O2 and NO3
-, but this is rarely completed to the final electron acceptor, 
i.e. nitrogen gas. When oxygen is removed the reductases are de-repressed. A study 
showed that Nar required a period of 40 min to 3 h (Knowles, R., 1982) (vit Mateju et 
al., 1992), while Nir requires longer(ore than 4 hours) for de-repression because of 
stronger repression by oxygen (Knowles, R., 1982). N2Or seems to be the most sensitive 
enzyme to oxygen (M.J. Kampschreur, H. Temmink, R. Kleerebezem, m.S.M. Jetten and 
M. C.M. Loosdrecht, 2009). Consequently in case of low oxygen concentration, 
denitrification results into high nitrous oxide emissions. 
During denitrification nitrate is reduced to nitrogen gas and protons are consumed. 
The process produces 3.57 g CaCO3 equivalents per 1 g of NO3-N reduced (G. 
Tchobanoglous, F. L. Burton and H.D. Stensel, 2003), with consequent increasing pH 
tendency. In traditional WWTPs, denitrification is coupled with nitrification. Since 
nitrification consumes alkalinity, the two processes have opposite requirements and 
the pH is partially balanced (Henze M. et al., Biological Wastewater, 2008). The 
optimum pH range for denitrification is 7.0–8.0 (Knowles, R., 1982), but denitrification 
was found to occur at lower rates also at pH up to 11 (Knowles, R., 1982). Experimental 
assessment on pure cultures showed that the emissions of N2O increased when pH was 
not in the optimum range, being maximum at pH 8.5 and 6 (M.J. Kampschreur, H. 
Temmink, R. Kleerebezem, m.S.M. Jetten and M. C.M. Loosdrecht, 2009). 
Finally, the availability of biodegradable organic carbon also limits denitrification. 
Carbon source availability depends both on quantity (mgCOD/L in pre-clarified influent) 
and on quality (readily biodegradable versus slowly biodegradable COD). The 
requirement can be expressed as COD/N-NO3, which can be highly variable depending 
on the quantity and quality of influent COD. Stoichiometrically, 2.86/(1-YH) mgCOD are 
required to completely reduce 1 mg of NO3-N. Due to significance of electron 
availability of denitrification, expressed by the COD/NO3-N ratio, this factorwas 
reported to affect the production of nitrous oxide more than other factors (Y.C.Chiu, 
M.S.Chung, 2003). 
1.2 Fate of pharmaceuticals in conventional wastewater 
treatment 
Since the efficiency of human metabolism is variable (20%-50% of the administered 
dose may be excreted as the parent compound, (Sterner O., 2010)), pharmaceuticals 
can reach WWTPs in the form of parent compounds and metabolites (including Phase II 
conjugates). As mentioned before, WWTP effluents are the most relevant sources of 
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emission of pharmaceuticals to the aquatic environments (Kaplan S., 2013), mostly as a 
result of the fact that WWTPs have been historically designed to remove exclusively 
conventional pollutants (COD and nutrients).  
Biological treatment is generally the step where most of the removal influent loads of 
pharmaceuticals occurs. The fate processes identified include  
 biotransformation of parent by microbial communities  
 sorption-desorption  
 biological retransformation of metabolites and/or conjugates to the parent 
compound. 
The observed removal efficiency for pharmaceuticals and contrast media is used to 
screen substance according to their persistence in biological wastewater treatment. 
This parameter can be defined as:  
                  ⁄      
In general removal efficiencies can vary significantly among WWTPs and depend on the 
applied treatment technology. Up to now the only effective treatments are the 
sorption onto sludge, and the biological transformation (Ternes T.A. and Joss A., 2006).  
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Table 11-1 apparent removal of pharmaceuticals in traditional WWTP 
compoun
d 
plant 
influent 
concentration 
[ng/L] 
effluent 
concentration 
[ng/L] 
apparent 
removal 
[%] 
reference 
Diclofenac 
Källby, 
Sweden 
160 120 22 (J.L. Zhou et. al, 2009) 
 
Scaynes Hill, 
UK 
397 119 70,1 (J.L. Zhou et. al, 2009) 
 
Manor Farm 
Road, UK 
782 176 77,5 (J.L. Zhou et. al, 2009) 
 
Basingstoke, 
UK 
981 78 92 (J.L. Zhou et. al, 2009) 
 
Greifensee, 
CH 
1185 620 47,7 
(Buser H.R. Poiger T. and Muller 
M.D. , 1998) 
 
**5WWTPs, 
FIN 
350 170 51,4 (Lindqvist N., 2005) 
 
Howdon, UK 1000 290 71,0 
(Roberts P.H. and Thomas K.V., 
2005) 
 
**4WWTPs 
Sevilla, 
Spain 
720 530 26,4 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
average 
  
57,3 
 
Carbamaz
epine 
Källby, 
Sweden 
1680 1180 30 (J.L. Zhou et. al, 2009) 
 
Sheffield 
Park, 
England 
1786,5 525,5 70,6 (J.L. Zhou et. al, 2009) 
 
Scaynes Hill, 
UK 
1662 950 42,8 (J.L. Zhou et. al, 2009) 
 
Manor Farm 
Road, UK 1237 637 48,5 (J.L. Zhou et. al, 2009) 
 
Basingstoke, 
UK 
1833 837 54,3 (J.L. Zhou et. al, 2009) 
 
**4WWTPs 
Sevilla, 
Spain 
1690 1000 40,8 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
average 
  
48 
 
Propanolo
l 
Cilfynydd,W
ales 
542 388 28 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
Källby, 
Sweden 
50 30 32 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
Scaynes Hill, 
UK 334 62 81,4 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
Manor Farm 
Road, UK 
690 134 80,4 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
Basingstoke, 
UK 
1090 110 89,9 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
**4WWTPs 
Sevilla, 
Spain 
390 340 12,8 
(J. Martín, D. Camacho-Mu˜noz, 
J.L. Santos, I. Aparicio, E. Alonso, 
2012) 
 
average 
  
62,34  
x-ray 
contrast 
media 
average 3840 2100 45,3 (K. Fent et al., 2006) 
 
Biological processes are capable of degrading pharmaceuticals, evidences have been 
provided both for lab scale systems (Carballa M. et al. O. F., 2007) (Carballa M. et al. O. 
F., 2006) and for industrial plants, tab. 2.2. Other studies show that the applied 
technology and the reactor-design are the most relevant factors to optimize the overall 
performance of the biological treatments (Falas P. et al., 2012) (Plosz B., 2007). The 
“intensification” of biological processes is one of the feasible solutions (Grady Jr. et al., 
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Biological wastewater treatment, 1999) (Plosz B. et al., 2003) and “reactor staging” is a 
promising technic to achieve high reaction rates (Plosz B., 2007). 
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1.2.1 Reactor staging as process optimization 
A number of studies on the activated sludge show that by reactor staging it is possible 
to achieve high reaction rates and an optimized design. Higher performances rely 
mainly on the specialization of the bacterial community to the specific conditions in 
each stage. This hypothesis has been so far  tested for denitrification with activate 
sludge (Sean E. Scuras, A. Jobbagy and C.P. Leslie Grady Jr, 2001). A staged 
configuration requires shorter sludge retention time and less amount of biomass to 
achieve comparable performance of unstaged configuration. Furthermore if the 
reactor operates at low biomass concentration, less biomass flux into the 
sedimentation and the required settler area is reduced (Sean E. Scuras, A. Jobbagy and 
C.P. Leslie Grady Jr, 2001). An optimum of three reactors in series for the staged 
configuration has been indentified (Plósz, 2007), providing for overall higher 
conversion rates as compared to unstaged configuration and increased flexibility. It has 
been also hypothesized that, due to the uptake of readily and slowly biodegradable 
COD in the first two stages, more recalcitrant organic chemicals could be degraded in 
the last stage configuration. (Scuras et al., 2001; Plósz, 2007). 
Further compared assessment of staged and unstaged configurations for denitrification 
of landfill leachate has been performed using biofilm systems (REFERENCE). 
Conceptual approach of reactor staging  
The conceptual approach for the staging of an anoxic reactor is already discussed by 
Scuras et al. (2001)and Plósz (2007) and Here we briefly present the most relevant 
steps in order to understand how optimize the dimension of stages in the staged 
configuration. 
The heterotrophic denitrifying bacteria in the biofilm oxidize nitrogen species as 
electron acceptors and use organic compounds as electron donor. The rate of 
denitrification depends also on the availability of biodegradable substrates, and it is 
optimum if the electron donors are not limiting. The availability of biodegradable 
compounds depends both on quantity and quality of the substrate. Considering the 
Activated Sludge Model No.1 structure and nomenclature ( (Henze M. et al., Biological 
Wastewater, 2008), the ready biodegradable fraction (Ss) is immediately available, 
while the particulate fraction (Xs) need to be first hydrolysed to Ss. Thus if Ss is not 
available, the hydrolysis of Xs is the limiting step Biomass decay is also providing new 
particulate biodegradable fraction; it liberates inert biomass debris (XP) and Xs, which is 
further hydrolysed to Ss, (Grady Jr. et al., Biological wastewater treatment, 1999) (Plosz 
B. Gy., 2007) (Madigan M. T. and Martinko J.M., 1970). 
The amount of COD theoretically required for the complete oxidation has been 
estimated by stoichiometric calculations. Assuming that the heterotrophic yield is 0,71, 
the following equation estimated the ratio COD/ NO3-N to denitify 1 mg of NO3-N 
denitrified to N2 (Henze M. et al., Biological Wastewater, 2008); 
    
   
       
      ⁄           
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The amount of denitrified nitrates is approximately the difference between the 
incoming and the outgoing flux (Plosz B. Gy., 2007), by the previous COD/NO3-N ratio 
we estimate the amount of COD theoretically reduced; 
(         )
    
    
                    
And if XH is the active biomass in the continuously stirred reactor, then: 
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where qS (mgSNO3/mgCOD*h),  the specific substrate utilization rate and it is the ratio of 
the specific growth rate, μH (h
-1), and the observed growth yield, YH (mgCOD/mgCOD). 
For an hypothetical unstaged configuration, the previous equation becames: 
     
 
 (         )
       
    
 
  
 
  
 
Whereas for a series of CSTRs, where the effluent of tank n-1 is the influent of tank n: 
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Assuming that XH is constant in the reactors, the followings are also valid (Plosz B. Gy., 
2007): 
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Knowing the specific denitrification rates rd (e.g. through batch experiments), we can 
estimate the required hydraulic retention time to achieve that removal. The optimum 
design of the stages based on the rate of denitrification, this depends on the substrate 
available in each reactor.  This kinetic-control design ensure the best exploitation of 
the volume available in each reactor.  
1.2.2 Biofilm and MBBR 
As opposed to suspended biomass systems, biological wastewater treatment in biofilm 
systems is performed by microorganisms attached to physical surfaces. The biofilm 
structure consists of bacteria imbibed in a matrix of extracellular polymeric substances 
(EPS). The EPS is made of free nucleic acids and water, it acts as glue and holds the 
biofilm onto the surface of attachment (also knows as “substratum”).  
Biofilm exhibits structural, chemical and biological heterogeneity. The whole structure 
is ideally divided in three compartments: the bulk liquid, the boundary layer, the 
biofilm itself and the substratum, which supports the biofilm (Grady Jr. et al., Biological 
wastewater treatment, 1999) (Henze M. et al., Biological Wastewater, 2008). The 
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metabolic activities within the biofilm layer and the diffusion process generate 
concentration gradients of nutrients, signalling compounds and bacterial waste 
(Stewart P.S. and Franklin M.J., 2008). These processes drive the mass transport of 
substrates through the entire biofilm layer and diffusion may be the limiting process, 
hindering substrate degradation (Odengaard H., Rusten B. and Westrum T., 1994) 
(Odenaard, 2006). The substrates availability, together with the bacteria location, also 
affects the microbial competition. Bacteria respond to gradients and adapt to the local 
chemical and physical conditions and differentiation occurs within the biofilm layer. 
The organisms on the surface access easily to the substrate but they are more 
frequently washed out, vice versa the bacteria living deeply in the layer are protected 
from detachment. These conditions may eventually change and biofilm evolves over 
time (Stewart P.S. and Franklin M.J., 2008).  
The most significant advantage of biofilm systems, as opposed to activated sludge, 
relies in the fact that biofilm reactors generally do not require a following biomass 
separation (e.g., a settler) process (Henze M. et al., Biological Wastewater, 2008) and 
biomass recirculation (Grady Jr. et al., Biological wastewater treatment, 1999), 
resulting in less space demanding treatment plants. 
Three types of biofilm reactors are generally distinguished (Henze M. et al., Biological 
Wastewater, 2008): non submerged system, submerged fixed bed biofilm reactors and 
different kinds of fluidized bed reactors 
With respect of XOCs, examinations on biofilm systems and on traditional activated 
sludge reactors, the latter operating at longer hydraulic retention time, showed 
comparable removal of several pharmaceuticals (Falas P. et al., Suspended biofilm 
carrier and activated sludge removal of acidic pharmaceuitcals, 2012) (Gobel A., 2007). 
Higher removal rates per unit of biomass were also shown for biofilm systems (Falas P. 
et al., 2012).  
Biofilm have performances similar to the activate sludge system, but many more 
advantages have been experienced by using biofilm. The main difference is that in the 
biofilm microorganisms are immobilized on a carrier, while for the activate sludge they 
are free to move in the reactor. The biofilm structure consists of bacteria imbibed in a 
matrix of extracellular polymeric substances (EPS). The EPS is made of free nucleic 
acids and water, it acts as glue and it holds the biofilm on the carrier which is a non-
permeable solid support (James P. McQuarrie and Joshua P. Boltz, 2011). The carriers 
differ on material, shape and mobility; we distinguish three types of biofilm reactors 
(Henze M. et al., 2008): non submerged system, submerge fixed bed biofilm reactors 
and different kinds of fluidized bed reactors. 
Biofilm exhibits structural, chemical and biological heterogeneity. The whole structure 
is ideally divided in three compartments: the bulk liquid, the boundary layer, the 
biofilm itself and the carrier, which supports the biofilm (Grady Jr. et al., Biological 
wastewater treatment, 1999) (Henze M. et al., 2008). The metabolic activities within 
the biofilm layer and the diffusion process generate concentration gradients of 
nutrients, signalling compounds and bacterial waste (Stewart P.S. and Franklin M.J., 
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2008). These processes drive the mass transport of substrates through the entire 
biofilm layer and diffusion is the limiting process. Indeed it is very slow and it limits the 
availability of substrates and consequently the biodegradation of these chemicals 
(Odengaard H., 1994) (Odenaard, 2006). The substrates availability, together with the 
bacteria location, also affects the microbial competition. Bacteria respond to gradients 
and adapt to the local chemical and physical conditions and differentiation occurs 
within the biofilm layer. The organisms on the surface access easily to the substrate 
but they are more frequently washed out, vice versa the bacteria living deeply in the 
layer are protected from detachment. These conditions may eventually change and 
biofilm evolves over time (Stewart P.S. and Franklin M.J., 2008). 
Examinations on biofilm and on traditional activated sludge reactors show comparable 
removal of several pharmaceuticals, but longer hydraulic retention time in the 
activated sludge process (Falas P. et al., 2012) (Gobel A., 2007). Indeed the biofilm has 
higher removal rates per unit of biomass (Falas P. et al., 2012). Furthermore the 
following advantages have also been demonstrated:  
 As soon as the biomass is active, the biofilm reactor does not require settler 
(Henze M. et al., 2008) and no recirculation of the biomass, as in the activated 
sludge systems (Grady Jr. et al., Biological wastewater treatment, 1999); these 
result in less space demanding plants; 
 The biomass separation is 10 times lower (Odenaard, 2006) and final sludge 
separation is not necessary. 
Based on these considerations the interest for biofilm reactors increased in the last 
decade and recently a new technology has been developed; it is known as moving bed 
biofilm reactor (MBBR). The MBBR adopts the best of the activated sludge technology 
and it is an intermediate technology between the activate sludge and the biofilm. The 
innovative feature of MBBR is that the carriers are free to move within the reactor and 
the whole tank is available for the biomass growth. The MBBR optimizes the use of the 
volume available in the reactor and it achieves a high homogenization level. The MBBR 
is also very flexible and it operates on different conditions (Rusten B., 2005). Even if it 
was originally developed for the nitrification (Rusten B., 2005), today MBBR is used also 
for the organic removal, the phosphorus removal and de-nitrification (Odenaard, 2006) 
(Henze M. et al., 2008).  
The carriers of the MBBR are designed to provide a large protected surface area and 
optimal conditions for the bacteria culture. They are usually made on high density 
polyethylene (0.95 g/cm3). The density of polyethylene is close to water density and 
this facilitates the suspension even with low mixing energy. There are many types of 
carrier; they differ on dimension, thickness and geometry. Depending on the selected 
carriers, the producer suggests the optimal filling ratio, which is the most important 
parameter to design MBBR. The filling ratio is defined as the volume occupied by the 
carriers in the empty reactor (Odengaard H., 1994), the maximum filling ratio used is 
about 70% (Rusten B., 2005). The standard filling ratio also influences the “carrier 
suspension” and the proper ratio ensures that the mixing is easily established. 
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Regarding to this, the turbulence is also important. It ensures the optimal diffusion of 
compounds through the biofilm layer. 
Since the type of carrier and the filling ratio affect the effective specific area available 
for the growth of biofilm, they are the most important reactor parameters. 
The MBBRs have been investigated on different configurations; different operational 
conditions and different substrates consumption have been monitored. Recently also 
the pharmaceutical removal in Swedish WWTPs has been documented (Falas P. et al., 
2012). It is proven that MBBR has superior removal capacity than the activated sludge, 
but the full potential is still to be explored and further investigations are required. 
1.2.3 Fate of XOCs in biological wastewater treatment systems 
In biological wastewater treatment systems,  XOCs, and among them pharmaceuticals 
(including metabolites), undergo a number of physico-chemical and biological fate 
processes. The most significant processes have been identified (Ternes and Joss, 2006, 
Plósz et al., 2010) 
 Biotransformation (i.e. one-step transformation) of dissolved parent 
compound forms,  
 Sorption to suspended particles and sludge particles 
 Retransformation of other dissolved fraction, e.g. conjugated metabolites, to 
the dissolved parent compound fraction   
Among other factors, the rate of biotransformation can depend also on the operating 
conditions that affect the degradation of the primary substrate. Indeed these 
conditions define the niche where the microorganisms live, grow and replicate. With 
regard to denitrification, the most relevant factors include the species of denitrifying 
bacteria occurring in the reactor, concentrations of biodegradable COD and of nitrate, 
DO concentration in the water, pH and the temperature (Ternes T.A. and Joss A., 2006) 
(Rittmann B.E., 1992) (Knowles, R., 1982). Within their niche the microorganisms 
consume growth substrates that supply carbon and energy. A distinction between 
essential substrates which are primary for growth and secondary and/or co-metabolic 
substrates is usually considered. Pharmaceuticals and XOCs generally belong to the 
second group due to their persistence and their low concentration, which is not able to 
support biomass growth (Rittmann B.E., 1992).  
Rittmann (1992) referred to biological transformation and degradation processes as 
“detoxification”, for which two possible mechanisms were described. In the first 
mechanism the microorganisms utilize the primary substrate as electron and energy 
sources but they consume also a fraction of the secondary substrates (Rittmann B.E., 
1992). In this case, XOCs are referred to as secondary substrate, being consumed when 
primary substrate concentrations are not sufficient. In case enzymes catalysing the 
consumption of primary substrates are active also for XOCs, co-metabolism occurs 
(Rittmann B.E., 1992). In the second mechanism the XOCs availability is high enough to 
trigger the specialization of microorganisms to the consumption of XOCs as unique 
substrate. In this case XOCs become primary substrates and higher removal of 
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contaminants is eventually achieved (Rittmann B.E., 1992).Under batch experiments 
conditions (with, e.g., activated sludge), XOC biotransformation can be described using 
pseudo first order kinetic (Ternes et al., 2006)  
  
  
 
        
  
              
where C is the dissolved XOCs concentration [μg*L-1 or ng L-1], , Xss the suspended 
solids concentration in the reactor [gSS*L-1] and kbio  the biotransformation rate 
coefficient [L*gSS-1*d-1]. Similar batch experiments with MBBR carriers (Falås et al., 
2012) showed that the biotransformation of pharmaceuticals could be described using 
the same kinetic equation. 
The biotransformation rate is proportional to the substance concentration C, where 
pseudo first order refers to the concentration of biomass (Xss), assumed to be constant 
in the period of a batch experiment (Ternes T.A. and Joss A., 2006) (Plosz B. Gy., 2007). 
 
1.2.4 Pharmaceuticals and contrast media: sources, fate and toxicity  
The term pharmaceutical refers to prescription human drugs, non-prescription human 
drugs and their metabolites. 
The release of pharmaceuticals in the environment has been recognized as one of the 
emerging issue in the environmental chemistry (Heberer T., 2002), and it was also 
targeted as a research priority in the European Union 5th framework Programme for 
Research (Ternes T.A. and Joss A., 2006). The concern on pharmaceuticals , rather than 
on their acute toxic effects, focuses on the chronic toxicity. 
Little is known about how pharmaceuticals behave and their effects on the 
environmental ecosystems where they enter. Since pharmaceuticals are biologically 
active compounds, even very small quantities (fig.1) may have harmful effects (Jones 
O.A.H. et al., 2011). Recently the aquatic organisms have been indicated as an 
important target (K. Fent et al., 2006). Indeed even if medications are designed to 
target specific metabolic pathways in the human body and in domestic animals (in case 
of veterinary uses), they may explicit similar function on non-targeted organisms and 
cause direct or in-direct changes on the whole ecosystems (Halling-Sørensen B., 1997) 
(Wilson B.A. et al., 2003) (Fair P.A., 2009) (Guler Y. and Ford A. T., 2010). Moreover, 
nowadays we ignore the modes of action of each compound on the many potential 
receptors and it is hard to predict direct and in-direct changes on the ecosystems 
(Daughton, 1999). Since in the aquatic environments pharmaceuticals have been 
detected at low concentrations, they are supposed to pose low risk for acute toxicity 
(K. Fent et al., 2006). On the other hand the situation is different for the potential 
chronic effects and more is to be investigated. The complete understanding of the 
environmental risk should also consider that organisms are exposed to a highly variable 
“cocktail” of medications and this condition is very difficult to be investigated.  
Nowadays the global consumption of pharmaceuticals is estimated to be around 
100,000 t a-1 per year (Ternes T.A. and Joss A., 2006). Consumption in industrialized 
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countries represents the main fraction of the total global use and it varies between 50 
and 150 g cap-1 a-1 (Ternes T.A., 1998). In table 1.1, we reported the consumption of 
the most widespread medications in some European countries. 
Thus the reason of environmental concern is mostly because WWTPs fail in the 
treatment of XOCs and that we ignore the potentially serious effects on the 
environment (Heberer T., 2002) (Ternes T.A. and Joss A., 2006) (Ternes T.A., 1998) (J.L. 
Zhou et. al, 2009).  
Two approaches to the problem have been suggested and discussed so far. The first 
strategy relies on “minimization and prevention”. According to this the less 
pharmaceuticals are produced and consumed the less compounds eventually reach the 
environment (Kaplan S., 2013). The second approach aims to tackle the discharge of 
chemicals in the short term period by the optimization of traditional WWTPs. 
Regarding to this; biological treatments and innovations in the more design of the 
reactors have very big potential to face the problem (Plosz B., 2007). 
Probably a more accurate design of the compounds on the market is also a key factor. 
Indeed an highly refined and efficient medication may require a lower dosage and the 
lower is the consumption of medications, the less will be the amount of pollutants 
reaching the environment. 
1.2.5 Routes of pharmaceuticals exposure 
There are many potential routes by which pharmaceuticals reach the environment (Fig. 
1.2). Here we shortly present the most important ones. First of all, the manufacture 
and the disposal of pharmaceutical waste have been strictly regulated and severe 
thresholds currently apply. Therefore, water contamination from waste disposal by 
manufacturers, wholesalers, retailers and hospitals can be considered a remote event 
(Jones O.A.H. et al., 2011). 
On the other hand, emission pathways related to human consumption are significant 
mainly because of excretion with urines and faeces. Pharmaceuticals are designed to 
explicit a curing effect and their performance varies according to chemical and physical 
properties, defined e.g., by the chemical composition and the molecular geometry 
(Sterner O., 2010). After the uptake pharmaceuticals are retained in the organisms 
until the curing effect is accomplished (Sterner O., 2010) (Ternes T.A. and Joss A., 
2006). ,Substances are usually metabolized in the liver and excreted through urines or 
faeces. Excreted forms include the unchanged parent substance and the metabolites, 
which include conjugates. Metabolites in water can be as persistent as the parent 
compounds (Halling-Sørensen B., 1997). By this route a wide range of pharmaceuticals 
and their metabolites are released into the sewage system and reach municipal 
wastewater treatment plants (WWTPs). 
Since traditional WWTPs are not able to achieve complete removal of pharmaceuticals 
their effluents have been detected as the most notable pathway by which 
pharmaceuticals reach surface waters and ground waters (Kaplan S., 2013) (Daughton 
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C.G., 2003). In this thesis, this has been considered the main route of 
emission/exposure and is highlighted in red in Fig. 1.1. 
Pharmaceuticals regularly disposed as solid waste are usually incinerated or landfilled. 
While in the first case they are completely oxidised, if landfilled they may eventually 
reach the ground waters by leaking through failures in the landfill liners (Jones O.A.H. 
et al., 2011). 
Pharmaceuticals and contrast media have been detected in a wide variety of aquatic 
environments including surface waters, groundwater and drinking water (REFERENCE). 
Concentrations in treated wastewater effluents range from the low ng L-1 to low µg L-1, 
while in the aquatic environment concentrations are generally lower (up to 1µg*L-1) 
(Jia-Qian Jiang et. al, 2013) (J.L. Zhou et. al, 2009) The highest environmental 
concentrations have been detected next to point sources, such as in proximity of 
WWTP discharges (Ternes T.A. and Joss A., 2006). 
A number of studies have highlighted and investigated the problem of environmental 
release of pharmaceuticals in different countries (Halling-Sørensen B., 1997) (Kaplan S., 
2013) (Daughton, 1999) (Jia-Qian Jiang et. al, 2013) (J.L. Zhou et. al, 2009). The highest 
number of compounds detected in the environment is 3000 pharmaceuticals (Ternes 
T.A. and Joss A., 2006), among these 80-100 pharmaceuticals and metabolites are 
commonly detected in different water bodies (Ternes T.A. and Joss A., 2006). Fig. 1.1 
shows the concentrations of the most ubiquitous pharmaceuticals in treated sewage 
and surface water reported until year 2006 (K. Fent et al., 2006).  
 
Figure 1-1 Concentration of pharmaceuticals in treated sewage (a) and surface water (b) in U.K. (K. Fent 
et al., 2006) 
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Figure 1-2 Exposure routes of pharmaceuticals into water bodies; the red line represent the focus of this 
thesis which is the most relevant route of exposure to the aquatic environment (Heberer T., 2002) 
(Ternes T.A. and Joss A., 2006) (Jia-Qian Jiang et. al, 2013) 
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1.3 Thesis aims and research hypothesis  
The overall purpose of this project is to investigate the performance of lab-scale 
unstaged and staged anoxic MBBR as innovative technology for the removal of 
conventional (i.e. nitrate) and trace organic pollutants (i.e. pharmaceuticals) from 
municipal wastewater. More specifically, the objectives of the thesis are: 
 To assess and compare the denitrification performance of 3-staged and unstaged 
MBBR reactor configuration under continuous flow conditions, using real municipal 
wastewater as feed; 
 To assess and compare the removal of eight representative pharmaceuticals 
(atenolol, propanol, metoprolol, trimethoprim, carbamazepine, diclofenac, 
sulphamethoxazole, and venlafaxine) in the staged and unstaged MBBR under 
continuous flow operation; 
 After a sufficiently long period of continuous operation, assuming that steady state 
is reached in terms of biomass characteristics, to assess and compare biological 
kinetics of denitrification in staged and unstaged MBBR reactors by means of 
targeted batch experiments; 
The assessment of the experimental set-up implied the verification of the following 
hypotheses: 
 In the staged configuration, bacteria adapt and specialize to the substrate available 
in each reactor. In this way, XOCs may potentially be the only available 
carbon/energy source in the last reactor and bacteria may specialize to use them 
as substrate. The specialization of the bacterial community could be expressed by 
different metabolic kinetics, different composition in the bacterial community 
and/or different enzymes expression.  
 The evolution of the bacterial community in the staged configuration during the 
adaptation period is responsible for higher removal rates of conventional and 
xenobiotic pollutants.  
 Considering the results of the batch experiments, the optimization of the design of 
the staged configuration could result in the achievement of higher performances 
with the same overall volume.  
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2 Methods 
In this chapter we provide the descriptions of the set-ups for the continuous flow 
experiment and for the batch experiments. We also describe the analytical methods by 
which we monitor the performances and the active biomass in the biofilm of each 
reactor. The protocols for the all analysis are in the appendices. 
We were running the continuous flow reactors since the beginning of December 2013 
until the end of March 2014. In the first two month of operation we tested different 
operational solutions, consequently we experienced fluctuations in the performances 
and data from the first two months are not reliable to discuss the research hypotheses. 
In the end of January we started to control the pH level in the storage tank and this 
was the last change in the operating conditions. Apart from the quality of the feeding 
medium, since the 29 of January the system operated at constant operating conditions 
for 55 day in a row. By monitoring the removal of conventional pollutants and XOCs in 
this period we discuss the performances of the two configurations. In the beginning of 
March we stopped the continuous flow reactors in order to run the batch experiments. 
The batch experiments have been performed on the same operating conditions of the 
continuous experiment; the filling ration and the amount of biomass have been also 
constant. By the observations on the batches we aim to estimate the rates of 
denitrification first and later to optimize the staged reactor design according to the 
procedure by Plosz (2007) for the activate sludge. 
2.1 The continuous experimental set-up 
The set-up of the continuous flow experiment consists of two anoxic moving bed 
biofilm reactors on a laboratory scale employing K1 carriers from AnoxKaldnes, figure 
2-1. The set-up is similar to that one of Plosz (2007). It consists of a staged and an 
unstaged line disposed in parallel. The staged line is composed of three sub-reactors in 
series, while the unstaged line is made up of one single reactor. The two lines are 
running on the same operating conditions (volume, hydraulic retention time and 
feeding medium) and by comparing them we evaluate the reactor staging as 
optimization tool. 
 
Figure 2-1 cultivated K1 Anoxkaldnes 
In the end of December we measured the biomass growth in the reactors and we 
observed that it differs among the reactors; on this fact we assumed that somehow the 
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bacteria communities in the reactor are responding differently to the specific operating 
conditions and to the availability of substrate among others parameters. In the end of 
January we also started to control the pH level in the storage tank and this was the last 
change in the operating conditions. Despite of the quality of the feeding medium we 
assumed that the operating conditions did not change since the 29 of January. The 
continuous experiment operates for 55 days in a row from the 29 of January to the end 
of March.  
 
Figure 2-2 experimental set-up 
By this set-up, we investigate the hypothesis by which the diverse substrate available 
in the reactors along the staged line drives the specialization of the bacterial 
communities. With regarding to this we assumed that: 
 the ready biodegradable fraction (Ss) is almost entirely consumed in the first 
reactor (S1); 
 In the second reactor (S2) bacteria oxidize the last SS from S1 and new SS from 
the hydrolysis of the particulate biodegradable fraction (Xs); 
 In the third reactor (S3) the more persistent biodegradable fraction is still 
available for biodegradation and bacteria are supposed to evolve and 
specialize in order to consume this hardly degradable substrate.  
By measuring the removal of pharmaceuticals and by microbiological analyses in the 
two lines, we want to understand if any specialization is occurring in the staged 
configuration. Eventually this specialization results into a different bio-diversity in the 
reactors and a higher biodiversity in the staged line than in the unstaged line. We 
expected that the staged line has higher biodiversity and consequently higher 
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performances of nitrates reduction, of sCOD consumption and pharmaceuticals 
degradation. 
The staged line consists of three cylindrical “sub-reactors” in series.  Previous studies 
on staged activated sludge reactors indicate that no more than three tanks are 
required (Sean E. Scuras, A. Jobbagy and C.P. Leslie Grady Jr, 2001) (Plosz B., 2007). The 
first two reactors (S1 and S2) have same sizes; they are transparent PVC cylinders, 1 cm 
thick, 60 cm high and 7 cm in external diameter. The third one (S3) is again a 
transparent PVC cylinder, 60 cm high and 10 cm in external diameter. The reactors 
have respectively 1,5 L and 3 L volume capacity and the total volume capacity is 6L. 
Each reactor is connected to the next one by approximately 50 cm long PVC pipes of 
0,5 cm diameter. The un-staged line consists of one cylindrical reactor of 1 cm thick 
PVC with 6 L volume capacity, it is 80 cm high and 12 cm in diameter. 
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Figure 2-3 scheme of the experimental set-up 
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We estimated the required dimensions of the three reactors in the staged line by the 
optimizing procedure from Plosz (2007). The rates of removal have been estimated by 
simulating a batch experiment with WEST. The reactor specifications are summarized 
in the table below. 
Table 2-1 set-up dimensions 
Line reactor flow 
[mL/h] 
 
Reactor 
volume [L] 
Height 
[cm] 
Outer diam. 
[cm] 
Inner diam. 
[cm] 
Material 
UNSTAGED  625 6 80 12 11 PVC 
STAGED S1 625 1,5 60 7 6 PVC 
S2 625 1,5 60 7 6 PVC 
S3 625 3 60 10 9 PVC 
 
The four moving bed biofilm reactors (MBBRs) are filled with plastic suspended 
carriers, Kaldnes K1. We set a filling ratio of 30% to ensure the homogeneous mixing 
and the circulation of the carriers. AnoxKaldnes suggest 60% for K1, but the small 
diameter in S1 and S2 limit the maximum filling ratio. Continuously stirred reactors and 
circulation of the carriers are primarily achieved by sparging nitrogen gas (N2) with jet 
nozzles from the bottom of the reactors and secondarily by wastewater flowing 
through the system. The definitive adjustment of gas consumption accounts also for 
the removal of solids settling down in the reactors.  
By sparging N2, we also ensure low concentration of DO and no aerobic zones. We 
measured the DO concentration in the reactors on a daily basis during the sampling 
procedure; measurements have been performed with Dissolved Oxygen meters from 
WTW, the detected values are low in the scale of the instruments where the potential 
error might be relevant (HOW much). We experienced similar DO ranges in the four 
reactors; the minimum concentration was 0,34 mgO2/L in the S2 and the maximum 
was 0,45 mgO2/L in the unstaged reactor and in S1.  
Studies demonstrated that such concentrations may still inhibit the enzymatic activity 
and consequently the whole denitrification (vit Mateju et al., 1992). We provided the 
reactors with polystyrene lids and rubber sealings to further reduce the potential 
exchange of O2 between the air and the water surface. The DO concentrations in the 
reactors have been measured again with from S::CAN, the measurements confirmed 
the absence of DO in the four reactors. 
The feeding medium is pre-clarified wastewater from Lundtofte WWTP (Lyngby), every 
batch was stored in a 200 L tank for 4-5 days at the average temperature of 2-3 °C. The 
tank has been continuously mixed. The two lines are fed with a peristaltic pump from 
the loop for the recirculation. The flow rate is 15 L/d (625 ml/h) in both the lines and 
the entire set-up consumes 30 L/d. The two reactors have 6 L capacity each and the 
average hydraulic retention time (HRT) is 9,6 h.  
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The COD content naturally occurring in the medium is the only organic substrate 
available for the denitrification and no extra source of carbon is added. Nitrates are 
supplied in the form of dissolved Potassium Nitrates (KNO3). We supply very large 
amounts of nitrates in order to ensure that denitrification is not limited in any of the 
reactors. the solution is pumped by peristaltic pump directly into S1 and U, the flow is 
25 mL/h (3,8% of the total flow) and the concentration is 10 gKNO3/L.  
Table 2-2 set-up specification  
 
The biofilm´s origin – K1 AnoxKaldnes from Sjölunda WWTP (Malmo, SWE) 
The reactors have been filled with AnoxKaldnes K1 carriers already colonized from the 
post-denitrification anoxic reactor in Sjölunda WWTP (Malmo, SWE). The specific 
surface of K1 carriers is 530 m2/m3,  AnoxKaldnes estimated an average “carrier 
density” of 1000 carrier/L. The plant is designed for 550,000 population equivalents; 
the biological treatment consists of high-loaded activated sludge, nitrification with 
trickling filters and post-denitrification with MBBR. The anoxic reactor consists of two 
zones in series and the carbon is supplied in the first zone in the form of methanol. The 
dosage is quantified in order to ensure the complete consumption; the methanol is 
estimated to be entirely consumed in the first zone and here the bacteria are carbon 
limited. Since also in predenitrification configuration no extra source of carbon is 
supplied, we collected the carriers from the second zone in order to shorten the 
adaptation period. The biomass per carrier in the second zone is  2,9 mg/carrier and 
the concentration is 1,4 kgSS/m3. While the average concentration of classical biofilm 
ranges between 2 and 5 kgSS/m3; such low concentration can be caused by carbon 
source or nitrates limitation (M.Mases, I. Dimitrova, U. Nybeg, C. Gruvberger, B. 
Andersson, 2011). 
The feeding medium – wastewater from Lundtofte WWTP (Lyngby, DK) 
The feeding medium is pre-clarified wastewater from Lundtofte WWTP (Lyngby, DK). 
Lundtofte WWTP has been designed for a population of 135.000 person equivalents, its 
catchment area is 32 km2 and no hospitals are served. The sampling point in the plant is 
the sump between the primary settling tank and the aeration tank before the 
recirculation of the activated sludge. We were sampling around 200 L of pre-clarified 
wastewater every 4-5 days with dry weather conditions and mainly at 13:00 p.m., 
when the peak of flow occurs. 
Line reactor flow [mL/h] 
 
NO3 _flow 
[mL/h] 
NO3_dose [mg/L] Reactor volume 
[L] 
HRT  [h-1] 
UNSTAGED  625 25 20 6 9,6 
STAGED S1 625 25 20 1,5 2,4 
S2 625 25 20 1,5 2,4 
S3 625 25 20 3 4,8 
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We monitor the primary and the secondary metabolism in terms of nitrate removal, 
sCOD removal and pharmaceutical removal; 
                                                 
                                        
                                     
The previous equation required the screening for conventional pollutants and XOCs 
both in the inlet and in the reactors (CSTR assumption). Thus every batch of 
wastewater have been characterized the conventional pollutants and the trace 
organics. We measured the complete fractionation according to the guidelines of 
Roeleveld (2002) and Weijers (1999) and the concentrations of NO3-N, NH4, TP and 19 
pharmaceuticals. Furthermore the characterizations of the medium have been verified 
on the data of clarified wastewater provided by Forsyning A/S, the company managing 
the plant. The following parameters have been measured: 
 CODinf_tot; 
 sCODinf; 
 BOD7; 
 bCOD; 
 SI; 
 NO3-N; 
 NH4-N; 
 Total Phosphorus; 
 19 pharmaceuticals. 
The analyses have been performed on 1 L grab-sample collected from the storage tank 
in the laboratory. The soluble non-biodegradable fraction (SI) was measured on grab-
sample after the secondary sedimentation before the discharge in the Mølleån river. 
The concentrations of sCOD, SI and nutrients (N, P) are measured on samples filtered 
with sterilized 0,45μm filters from the Greyer. The quantification of CODinf,tot, sCODinf, SI 
and total phosphorus have been done with HACH-Lange test kits and a Hach-Lange DR 
2800 spectrophotometer for the quantification. We used test kits from MerckMillipore 
and Spectroquant NOVA 60 from Merck to measure the concentration of NO3-N, NO2-N 
and NH4-N. We measured the BOD7 with Oxitop OC 100 from WTW, each 
measurement have been triplicated. The data from the Oxitop have been treated with 
ACHAT.exe and SIGMAPLOT.  
The concentrations of pharmaceuticals have been measured with High Pressure Liquid 
Chromatography Mass Spectrometry/Mass Spectrometry (HPLC-MS/MS) with Ultimate 
3000 from Dionex. The samples have been collected with glass pipette in glass vials to 
avoid the adsorption; the samples are diluted with methanol before being stored at -
20°C. 
The following protocols are attached in the appendices:  
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 wastewater complete characterization according to Roeleveld (2002) and 
Weijers (1999);  
 BOD7 analysis and analysis; 
 use of test kits from Hach-Lange and MerckMillipore; 
 quantification of pharmaceuticals with HPLC-MS/MS. 
The pH-control system 
The complete denitrification produces 3,57 g of alkalinity as CaCO3 per 1 g of NO3-N 
reduced (G. Tchobanoglous et al., 2003). In traditional WWTP the alkalinity produced 
by the denitrification is consumed by the nitrification and the pH level is partially 
buffered because the two processes are “opposite”.  
In the continuous flow experiment the denitrification is the only process occurring and 
the pH level increases naturally and eventually it deviates from the optimum range (i.e. 
7-8). We measured the pH with portable pH meter from WTW. We experienced that 
the pH level in the storage tank after the sampling is usually greater than 7,4, but 
sometimes values around 7,6-7,8 have also been measured. In the staged reactor the 
pH increases along the line, the maximum level is reached in S3 and the average is 
close to that one in U. Furthermore, sometimes the pH in the tank increased during the 
period of storage. 
Considering the optimum pH range for denitrification (i.e. 7-8) and that the pH in the 
biofilm is greater than the pH in the bulk phase, we decided to dose acid in the storage 
tank in order to establish more advantageous conditions in the reactors or at least to 
avoid the inhibition of the process as much as possible. Thus from the end of January 
we were controlling the pH by dosing 1M solution of HCl. We roughly estimated that 8-
9 hours are required for the pH to reach high value again. 
Wastewater sampling for the conventional pollutants 
We were sampling for conventional pollutants since the system starts to operate. Since 
January 2014 we used to sampling every day in the morning. By sampling in the 
morning, we ensure that no perturbations occurred at least in a time period of 9 hours, 
which is the HRT of the system. If anything provoked the system to deviate from the 
ideal conditions, we delayed the sampling 9 hours later than the last perturbation. We 
were sampling the reactors in the staged line from downstream to upstream in order 
to minimize any perturbations on the system. Assuming that the reactor is completely 
mixed the effluents of the two lines have the same concentration as the wastewater in 
S3 and U. During sampling we observed the following procedure for each reactor: 
 opening the reactor; 
 flushing the syringe by pipetting back and forth the wastewater from the 
centre of the reactor; 
 collecting wastewater in the 10 mL syringe; 
 immersion of the pH meter; 
 the first 4 mL sample from each reactor are stored in a 6 mL labelled plastic 
flask; 
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 the second 10 mL sample from each reactor are filtered with 0,45 μm sterilized 
filter from The Geyer; 
The non-filtered sample is always been analysed just after the sampling, while the 
filtered sample is preferably analysed the same day of the sampling and then it is 
stored at 2°C in case of the analysis have to be repeated. By storing the samples in this 
way, we experienced that the results of the analysis with HACH-Lange test kits and 
Merck test kits do not change even after a period of 15 days. 
Wastewater sampling for the pharmaceutical screening 
In the last two weeks of operation we were sampling for the quantification of 
pharmaceuticals as XOCs. During the first week we sampled from the all reactors every 
second day after the collection of the medium, in the second week the samples have 
been collected daily until the end of the continuous experiment. We sampled also from 
each batch of water after the collection in Lundtofte. The observed removals for each 
chemical have been estimated by calculations on the mass balances. 
The sampling procedure has been suggested by the department of Environmental 
Chemistry and Microbiology of Aarhus University in Roskilde. They also developed the 
method and the protocols for the quantification of the targeted micropollutants. The 
samples have been analysed in the end of the experiment, in the meanwhile the 
samples have been stored at -20 °C. In order to avoid any sorption of trace organics on 
plastic materials, we used new glass pipettes for every set of samples. The sampling 
procedure consists of: 
 pipetting 10 mL of wastewater with glass pipette in a 14 mL glass vial; 
 mixing the samples with 3,5 mL of methanol and storage at -20 °C until the 
analysis. 
Biomass sampling for TSS and microbiological analysis 
In order to minimize the depletion of biomass in the reactors within the operational 
period, we minimize as much as possible the sampling of biomass for the TSS 
measurement and for the microbiological analysis. 
The measurement of TSS has been repeated three times and we collected five non 
deformed carriers from each reactor for each quantification. In order to keep the filling 
ration constant within the operating period, the empty carriers have been replaced in 
the reactors after the biomass collection. With regarding to the microbiological analysis 
we sampled two carriers per week. Again, the empty carriers have been replaced in the 
reactors, in this way the filling ratio did not change during the operating period. The 
samples have been stored as pellets at -20°C until the operating period of the 
continuous flow experiment finished. The procedure for sampling and storing consists 
of: 
 brushing the carriers with disposable Gynobrush directly into a 1,5 mL 
Eppendorf tube; 
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 flushing the carrier with distilled water (the water is collected in the same 
Eppendorf tube as before); 
 centrifuge the biomass at 10.000 rpm for 5 minutes; 
 removal of the supernatant; 
 storage at -20°C. 
2.2 The batch experiments 
After 99 days of operation, we stopped the continuous flow experiment in order to 
perform the batch experiments on the same four reactors. We assume that in this 
period the bacterial communities adapted to the specific operating conditions and 
eventually the reactors perform at different denitrification rate and show different 
elimination of pharmaceuticals as XOCs. By the batch experiments we aim to estimate 
the denitrification rates, the specific denitrificaiton rates and to observe the 
elimination of some of the pharmaceuticals that we were screening during the 
continuous flow experiment. 
In the batch experiment the substrates and the biomass are placed almost 
simultaneously, the process proceeds for 24 hours. By continuous sparging N2 we 
provide homogeneous mixing and anoxic conditions. 
The pH level in the batches is controlled by dosage of 1M HCL until pH 7 is reached; 
before the start of the experiment and whenever it reaches very high level in any 
reactors; the pH is continuously monitored. The temperature is monitored but not 
controlled  (appendix G). 
The four reactors operate on the same conditions, same feeding medium and 20% 
filling ratio (lower than in the continuous flow experiment). In order to operate at 
constant filling ratio during the entire experiment, after each sampling a precise 
number of carriers has been removed.  
The feeding medium for the experiment is pre-clarified real wastewater from 
Lundtofte WWTP. The medium has been collected in the same day of the experiment; 
its quality has been characterized according to the guidelines from Roeleveld (2002) 
and Weijers (1999), as we did for the continuous flow experiment (appendix B). The 
medium has been screened for 19 pharmaceuticals via HPLC-MS/MS with Ultimate 
3000 from Dionex. The method for the quantification of micropollutants has been 
developed by the department of Environmental Chemistry and Microbiology of Aarhus 
University in Roskilde, (appendix F). 
2.2.1 Estimation of the biological kinetics   
On the results from the batch experiment, through the method presented by Kujawa 
and Klapwijk (1998) the following parameters have been estimated for the fours 
reactors: 
 Denitrification rates (r1, r2 and r3); 
 Specific denitrification rate (K1, K2, K3); 
 Growth yield (Yh); 
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 Maximum growth rate (μh). 
In WWTP denitrification occurs with wastewater as electron donor and three rates are 
identified depending on the COD fraction utilized, (Henze M. et al., 2008) (K.kujawa 
and B.Klapwijk, 1998). These are the soluble biodegradable (SS), the particulate 
biodegradable (XS) and the particulate biodegradable by decay of biomass (XS,BH).  
Three different linear phases describe the reduction of nitrates, (K.kujawa and 
B.Klapwijk, 1998); they occur simultaneous until the substrates are consumed. The 
denitrification on SS is the fastest and this is the first fraction to be consumed, XS has 
lower denitrification rate and XS,BH in the lowest. The process gets in the endogenous 
phase when XS,BH is the only available substrate (K.kujawa and B.Klapwijk, 1998). Since 
denitrification occurs exclusively on SS, the utilization of XS and XS,BH is slower because 
driven the hydrolysis is required. 
The production/accumulation of NO2-N is not negligible and we account for it in the 
calculations; the nitrate utilisation curve is built on NO3-N+0.6*NO2-N as suggested by 
Kujawa and Klapwijk (1998). Where the correction factor is estimated by stoichiometry 
considering that 1 mg of NO2-N required as many electrons as 0,6 mg of NO3-N to be 
completely reduced to N2 (Henze M. et al., 2008).  
The slope in each phase is estimated by the following equation: 
 
  
                 
  
 
The quality of the consumed substrate affects the rate of denitrification, the slope in 
the utilisation curve changes according to the available substrate. Three slopes are 
observed: 
1.                      ; 
2.                ; 
3.           . 
By the quantification of the biomass in each reactor, we estimate the specific 
denitrification rate in each reactor (kDi) by the following: 
   
   
   
⁄  
As discussed by Kujawa (1998) and Ekama (2008), in the second phase the XS fraction is 
consumed. Considering this, we assume that the whole bCOD fraction in the feeding 
medium is oxidized to reduce the ΔNO3,2-N; this is estimated by the intercept of the 
linear regression that approximates the consumption of nitrates and nitrites over time, 
see the general case in the figure below. 
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Figure 2-4 estimation of ΔNO3,2-N according to Kujawa (1998) 
The methodology to estimate the denitrification rates has been discussed in par. 3.2.1. 
We approximate the utilization of nitrates and nitrites together (NO3,2-N) to a first 
order kinetic; 
     
        
  
        
Where ki represents the specific denitrification rate normalized per amount of biomass 
(mgNO3-N/h) and XBH the concentration of biomass in the reactors during the 
experiments, expressed as gCOD/L. 
Then the curve describing the utilization is a linear regression; 
         
where a  is the rate of utilization and yo the initial concentration. The interval time has 
been defined to have the highest R2 as possible. The initial concentration (100 mg 
NO3,2-N) is the only constrain in the regression. 
 
2.2.2 Estimation of growth yield and maximum growth rate 
The growth yield,     has been estimated by the following equation from the 
stoichiometry of the process (par. 2.3.1): 
         
    
                 
 
Where 2.86 mgCOD/mgNO3 is valid for the complete denitrification to nitrogen gas. 
Since we ignore if the process is complete and where in the chain it stops, we estimate 
the   for three possible scenarios: 
 Denitrification to nitric oxide, correction factor is 3/5;  
 Denitrification to nitrous oxide, correction factor is 4/5; 
 Complete denitrification. 
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The possible accumulation of nitrites has been excluded because the concentration of 
nitrites has been monitored both in the continuous flow experiment and in the batch 
experiment. 
In order to estimate the maximum growth rate (  ) we neglect the role of substrate 
diffusion through the biofilm. By this simplification the case of biofilm system is reduce 
to the activate sludge system. The specific denitrification rate in phase one (k1) is given 
by: 
   
         
       
 
  
     
 
Assuming that in the first phase the following is valid: 
      ; 
  
     
⁄    
From the previous one, we extract    for each reactor in the three scenarios.  
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2.3 The analytical methods 
In the following paragraph we describe the methods for the quantification of 
conventional pollutants, for pharmaceuticals (as XOCs) and for the biomass on the 
carrier. 
2.3.1 The analysis of conventional pollutants 
We measured the concentration of total COD, soluble COD (sCOD), NO3-N and NO2-N 
since the beginning of the operational period. In the last 40 days of operation we 
measured also NH4-N and total phosphorus (TP) concentration. COD fractions and 
nitrogen species are measured spectrophotometrically. 
The total COD and total phosphorus are measured on the unfiltered samples, while the 
others pollutants are measured on filtered samples with cellulose sterilized disposable 
45 μm filters by The Geyer. 
We measured the total COD, the soluble COD and the total phosphorus 
photometrically with HACH-Lange test kits (LCK 514, LCK 314, LCK 348 and LCK 350) 
and HACH-Lange spectroquant DR 2800 for quantification. Nitrates, Nitrites and 
Ammonium have been also measured photometrically; we used MerckMillipore test 
kits and spectroquant NOVA 60 from Merck for quantification. 
We assumed that the measurements of nitrates, nitrites and ammonium have normal 
distribution. We choose a confidence interval of 95% and the selected error on the 
measurements is two time the standard deviation. HACH-Lange itself calculated the 
standard deviation for every cuvette test on an international inter-laboratories test. 
LCK 514 has been evaluated on 358 measurements, LCK 314 on 274 measurements, 
LCK 348 and LCK 350 on 424 measurements. The standard deviation, ϭ, for each test is 
available in the quality certificates produced by HACH-Lange itself; the values are listed 
below: 
 ϬLCK514=2,9; 
 ϬLCK314=0,5; 
 ϬLCK348=0,091; 
 ϬLCK314=0,018. 
With regarding to MerckMillipore test-kits, we repeated the measurements of every 
parameters 6 times on the same sample. We assume that the 6 values distribute on a 
Gaussian curve and we select the same confidence interval (95%). Again the error is 
twice the standard deviation for each series. We assumed also that the estimated error 
does is constant and valid fr every measurement of the same parameter. Since for the 
ammonium test kit the sample is not diluted, its standard deviation is significantly 
smaller than the one of the other test kits. Indeed for the quantification of nitrates and 
nitrites we dilute the sample five times and the error on the measurement is 5 times 
the twice of the standard deviation on the nitrate test (?). The nitrates test kit has 
bigger error because the execution is more difficult. The values of standard deviation 
and the errors for the nitrates test kits is ϬNO3_N=2,93 mgNO3-N/L. 
  
46 
 
 
2.3.2 Screening for xenobiotics 
We monitored the concentration of 30 pharmaceuticals in the last 21 days of operation 
on contininuous flow configurations. The quantification consists of High pressure liquid 
chromatography- mass spectrometry/mass spectrometry (HPLC-MS/MS). The method 
has been developed by the department of Environmental Chemistry of Arhuus 
University in Roskilde.  
The HPLC-MS/MS is a dual low-pressure mixing ternary-gradient system Ultimate 3000 
from Dionex. The system is equipped with a pump of the 3000 series (DGP-3600 M), a 
3000 TSL autosampler (WPS 3000 TSL) and a column oven and degasser also from the 
Dionex 3000 series. The HPLC operates with two eight-port Valco valves. The mass 
spectrometer is an API 4000 (ABSciex, Framingham, MA, USA). The API 4000 operates 
in ESI in positive mode at 400°C with a capillary voltage of 5500 V. The HPLC operates 
following gradient elution of methanol and Millipore water, both containing 0.2% 
formic acid (v/v) on a Synergi-Polar column (Phenomenex, Torrance, California, USA). 
All the assessment is based on the peak areas. A multilevel calibration is performed 
with four repeats each. 
2.3.3 TSS measurements 
The applied procedure for the TSS measurement is similar to Dupla et al. (2006) and 
Falas et al. (2012). We estimated the TSS on the carriers three times during the entire 
period. Indeed the first data in the series is from M. Mases (2011). We did the analysis 
after 44, 74 days of running and at the end of the continuous experiment, immediately 
before the batch experiments. Every time we sample five carriers from each reactor, 
the mount of TSS is estimated as the average amount of biomass on each carrier. In 
order to not reduce the filling ratio too much, we repeat the analysis three times. The 
protocol for the TSS analysis is presented in details in the appendix C; it mainly consists 
of three steps: 
 Dry the biomass on the carriers by heating them at 105°C for 1,5 h and weigh 
them; 
 Remove the biofilm from the carrier by flushing with sulphuric acid (H2SO4) 4 
M, brushing and flushing again with water; 
 Dry the empty carriers by heating them at 105°C for 15 minutes and weigh 
them. 
The amount of biomass on the carriers is given the difference between the weight of 
the colonized carrier with dried biomass and the empty carrier after the biofilm 
removal. Assuming that the measurements have a normal distribution, we select a 
confidence interval of 95% and the error on the measurements is two time the 
standard deviation.  
Considering the estimations from Anoxkaldnes about the carriers concentration per 
litre and on the knowing the amount of biomass per carrier, by the following equation 
we estimated the total biomass (Mtotalbiomass) and the biomass concentration (mbiomass) in 
each reactor: 
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                              ⁄                  
Where f is the filling ration e Vreactor is the volume of considered reactor. 
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3 The continuous experiment - Results and discussion 
3.1  Denitrification 
3.1.1 Characterization of the feeding medium 
The feed for the continuous flow experiment was pre-clarified wastewater   from the 
Lundtofte WWTP waste water treatment plant in Lundtofte (Lyngby, DK). From 120 L 
up to 200 L of medium were collected  twice per week and stored in a tank at 
temperature 1-3  °C. Every  wastewater feed was characterized in terms of COD 
fractionation, NO3-N, NH4 and total phosphorus (TP) content. As shown in Fig. 3-1, we 
experienced significant fluctuations in the quality of the feed. Since the system 
required a certain time for adaptation to the medium, we believe these fluctuations 
affected the observed efficiencies during the continuous flow experiment. 
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Figure 3-1 Characterization of pre-clarified wastewater from Lundtofte WWTP (Lyngby, DK) in terms of 
COD fractionation (a, b) and nitrogen and phosphorus species (c). 
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3.1.2 Consumption of primary substrates  
Here we describe and discuss the primary metabolism of heterotrophic bacteria in the 
staged and in the unstaged system. The intensity of the process is investigated in terms 
of consumption of primary substrates: the sCOD as electron donor and the NO3-N as 
electron acceptor. The observed period is limited to a time period of 50 days, from day 
43 (beginning of the pH-controlled period) until day 88 (7 days before the batch 
experiment) of the entire operation period. During this period of time, we collected 9 
different  wastewater inocula. Due to variations of the amount of wastewater collected 
in each inoculum the period during which the system was running with the same 
medium changed.. With regard to the heterotrophic denitrification, the availability of 
COD as electron donor is expressed in terms of biodegradable COD and on its quality 
(particulate or dissolved). Since nitrate was supplied with constant dosage and in 
excess (100 mg/L), the system was operated under COD-limiting conditions. As 
indicators of denitrification, we investigated in each reactor nitrate removal (ΔNO3-N) 
and soluble COD consumption (ΔsCOD), where sCOD includes the fraction of readily 
biodegradable COD available for denitrification in the instant of sampling (Ss) plus the 
amount of inert COD (SI), assumed to be constant during for each feeding period. 
 The electron donor - ΔsCOD 
The plots in Fig. 3-2a show the rate of consumption of sCOD (ΔsCOD) over time in the 
unstaged and stagedconfigurations (a) and in S1, S2 and S3 of the staged MBBR (b). We 
observed signficant differences in ΔsCOD for every wastewater inoculum. The largest 
variations were registered in case of large fluctuations in the content of SS  (day 57, 63, 
70, 73). It could be observed that variations of ΔsCOD in both configurations with a 
change of medium were rather fast and ΔsCOD reached and a steady state was 
reached one day after the change of the feeding medium (feeds 5-9). 
At first we observed that the total sCOD was found to be the highest when when Ss 
concentration in the medium was also high (feed number 5), comparably low minimum 
when influent Ss was reduced (feeds 3, 6, 8). Fluctuations of ΔsCOD in S1 (ΔsCODS1) 
over time were significant if compared with ones in S2 (ΔsCODS2) and S3 (ΔsCODS3). 
ΔsCOD in S2 and S3 was rather constant and ranging between 0 mgCOD/L and 15 
mgCOD/L. 
ΔsCODS1 was also found to increase at higher influent  SS concentrations. 
Table 3-1 ΔsCOD and SS n batch num. 1, 2, 5, 6 
Num. batch  ΔsCODS1 (mgCOD/L) SS (mgCOD/L) 
1 64.7 72.7 
2 67.95 76.7 
5 103.12 103.84 
6 27.95 32.54 
 
This confirms the hypothesis by which the influent readily biodegradable fraction is 
mainly degraded in S1 and its bacterial community seems to have adapted to the use 
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of this substrate. Whenever influent Ss is less abundant (low quality of the medium) the 
process in S1 was less intense and a lower removal of sCOD was observed. 
As most of the utilization of Ss occurred in S1, the COD fraction available in S2 and S3 
for denitrification was likely to derive from the hydrolysis of the slowly biodegradable 
COD, XS and from endogenous respiration of decayed biomass (XH). Therefore, 
hydrolysis drove the denitrification in S2 and S3. A negative removal of sCOD (i.e. 
increased concentration from S1 to S2 or from S2 to S3) was observed in S3 and more 
rarely in S2, possibly indicating that extensive hydrolysis was occurring (e.g., as a result 
of detached biomass) and/or at higher rates than the utilization of Ss for 
denitrification.  
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Figure 3-2 (a) ΔsCOD in the staged and in the unstaged system; (b) ΔsCOD in S1, S2 and S3 in the last 44 
days of operativity, the red dashed lines represent the change in the quality of the feeding medium. 
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The electron acceptor - ΔNO3-N 
Nitrate removal (ΔNO3-N) trends over time are reported in Fig. 3-3.  The variation of 
ΔNO3-N was found to be more evident than in the case of ΔsCOD and no steady state 
removal was reached for nearly each feed Within day 70 and 73 we experienced the 
lowest ΔNO3-N, corresponding to a minimum in ΔsCOD. 
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Figure 3-3 variation of ΔNO3-Nstaged and ΔNO3-Nunstaged over time  
We also observed that the staged and the unstaged reactors performed differently. In 
Fig. 3-4, an explicit comparison of the performance of staged and unstaged reactors in 
terms of ΔNO3-N removal is shown.  The observations are based on averages within the 
time of running with the same feeding medium (9 different inocula are considered). 
The plot shows that the two reactor configurations had similar removal in batches 1, 3 
5 and 8. A higher average ΔNO3-Nstaged was registered for 7 out of 9 feeds in the 
operating period. The largest difference was observed for feed 6 (days 71, 72, 73) 
where the ratio ΔNO3-Nstaged/ ΔNO3-Nunstaged was found to be higher than 2. The 
peculiarity of this feed was the minimum concentration of sCOD, registered during the 
monitoring period.  
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Figure 3-4 Comparison of average ΔNO3-N removal in staged and unstaged reactors 
This observation may suggest that the staged configuration could perform well in 
critical conditions, e.g. with a diluted feed. Furthermore we suppose that the higher 
performance in the unstaged configuration is due to the robustness of S2 and S3. This 
is confirmed on the observed average ΔNO3-NS1, ΔNO3-NS2 and ΔNO3-NS3 in the 50 days 
of monitoring and in within day 71 and day 72,. 
Table 3-2 Average removal of NO3-N in the 50 days of operation and during days 71, 72 and 73 
Reactor ΔNO3-Nmean_50DAYS  ΔNO3-Nmean_71,72,73  
Unstaged 37.7 13.5 
S1 35.8 10.2 
S2 6.0 8.5 
S3 3.7 5.5 
 
Table 3-2 shows that the average removal in the entire period is higher overall for the 
staged configuration (45.5 mgNO3-N/L) than for the unstaged (37.8 mgNO3-N/L). In 
the staged reactor, most of the denitrification occurred in the reactor S1, being  is 
consistent with observations about ΔsCOD.  
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Table 3-3 ΔCOD/ΔNO3-N (mg COD/mgNO3-N) 
batch Staged Unstaged 
 ΔCOD 
(mgCOD) 
ΔNO3-N 
(mgNO3-N) 
ΔCOD/ΔNO3-N 
(mgCOD/mgNO3-N) 
ΔCOD 
(mgCOD) 
ΔNO3-N 
(mgNO3-N) 
ΔCOD/ΔNO3-N 
(mgCOD/mgNO3-N) 
1 61.52 40.54 1.52 62.24 43.2 1.44 
2 68.85 58.75 1.17 74.7 37.35 2.00 
3 31.04 63.5 0.49 27.36 52.17 0.52 
4 64.76 49.16 1.32 62.48 40.95 1.53 
5 107.06 28.8 3.72 106.9 33.4 3.20 
6 30.05 24.25 1.24 40.05 13.5 2.97 
7 59.675 55.2 1.08 61.65 36.45 1.69 
8 19.9 42.2 0.47 19.75 37.2 0.53 
9 60.55 50.5 1.20 62.9 33.5 1.88 
 
The average COD/NO3-N ratio ranges between 1.2 and 2 in 6 batches out of 9 (batches 
num. 1, 2, 4, 6, 7, 9), table 7. It is maximum in batch num. 5 both for the staged and the 
unstaged, in this batch 5 we also observed the highest values ΔsCOD (106.9 mg/L), low 
ΔNO3-N and the hisghest concentration of Ss in the feeding medium. The lowest 
COD/NO3-N ratio values are detected in batches 3 and 8. In these we observed low 
concentration of sCOD in the influent (fig. 5b), very low ΔsCOD (fig. 5a) and ΔNO3-N 
close to the average. 
We observe, fig. 3-2 and fig. 3-5, that the most of the NO3-N utilization occur in the first 
reactor. Because of that we expect that the denitrification rates are the highest in the 
system. Furthermore the staged system is more flexible to the fluctuations of the 
quality of the medium, we supposed that this is because of S2 and S3. The constant 
operation of S2 and S3 with regards to the variation of Ss in the feeding medium was 
probably due to constant carbon limited conditions. This confirms that somehow the 
bacterial community specialized to the specific conditions in S1, S2 and S3. In 
particular, S2 and S3 ensured an almost constant rate of degradation, which actually 
increased when minimum influent sCOD in the feed where observed. This affected 
positively the efficiency of the whole staged reactor and guaranteed higher 
performances than the unstaged configuration. 
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Figure 3-5 Cumulative removal of NO3-N in S1, S2 and S3 of the staged configuration 
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Figure 3-6 Concentrations of NO3-N in S1, S2 and S3 in the last 16 days of operativity (4 batches) 
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3.2 Removal of pharmaceuticals  
 In this paragraph, we present the occurrence of 22 pharmaceuticals in the feeding 
medium and the removal of 10 pharmaceuticals in the MBBR confiugurations over the 
28 investigated chemicals by the quantification method with HPLC-MS/MS. The 
measured concentrations corresponded to overall 6 samplings over 20 days of 
screening. 
In this paragraph we present the observed removal efficiency of selected 
pharmaceuticals in staged and unstaged configurations, based on concentrations 
measured in the feeding medium and in the different reactors.  
Removal efficiencies are presented and discussed for 10 pharmaceuticals. This 
selection was based on the possibility of detecting and quantifying concentrations in 
the dissolved phase of MBBR reactors..  Within these 10 chemicals, we observed 
different behaviours: gradual degradation along S1, S2 and S3, low and high rate of 
elimination and retransformation.  
Most of the pharmaceuticals undergo diverse physical-chemical and biological 
processes simultaneously; for this reason the discussion on the continuous flow 
experiment is limited to the comparison between the two configurations which 
operate under the same conditions. The comparison between the stages is mainly 
limited to the results from the batch experiment. 
3.2.1 Concentrations in the feeding medium 
The feeding medium is pre-clarified wastewater from Lundtofte WWTP. We detected 
22 pharmaceuticals in three different wastewater inocula collected within a time 
period of 20 days. Reported concentrations (Fig. 3-) are the average averaged of 
concentrations measured in the last three wastewater feeds (7, 8, 9). The most 
abundant compound is Triclosan (19 µg/L ) this result agree with the wide use of this 
chemical. Ciprofloxacin and Ibuprofen are also quantified in high concentration, 
respectively  13 µg/L and 4.4 µg/L. The less abundant are Phenozenone, Sulphadiazine 
and its metabolite Ac-Sulphadiazine. 
59 
 
 
M
e
to
p
ro
lo
l
A
c
e
ty
l 
S
u
lf
a
d
ia
z
in
e
D
ic
lo
fe
n
a
c
S
u
lp
h
o
m
e
to
x
a
z
o
le
A
te
n
o
lo
l
C
a
rb
a
m
a
z
e
p
in
e
ib
u
p
ro
fe
n
P
ro
p
a
n
o
lo
l
S
u
lf
a
d
ia
z
in
e
T
h
ri
m
e
th
o
p
ri
m
P
h
e
n
o
z
e
n
o
n
e
T
ra
m
a
d
o
lo
l
Io
m
e
p
ro
l
io
p
a
m
id
o
l
c
it
a
lo
p
ro
m
c
la
ri
th
ro
m
ic
in
s
u
lp
h
a
m
e
ti
z
o
le
v
e
n
la
fa
x
in
e
c
ip
ro
fl
o
x
a
c
in
c
lin
d
a
m
ic
in
e
ri
th
ro
m
ic
in
tr
ic
lo
s
a
n
n
g
/m
L
1e+0
1e+1
1e+2
1e+3
1e+4
1e+5
Lundtofte (ng/mL) 
 
Figure 3-7 pharmaceuticals concentrations in clarified wastewater from Lundtofte WWTP, Lyngby DK 
Table 3-4 concentrations of detected pharmaceuticals from Lundofte WWTP, Lyngby DK 
Compound  Lundtofte WWTP Influent (ng/L) 
Metoprolol (MET) 1441 
Ac-sulphadiazine (AC-SLF) 11 
Diclofenac (DCF) 293 
Sulphametoxazole (SMX) 141 
Atenolol (ATE) 361 
Carbamazepine (CBZ) 144 
Ibuprofen (IBF) 4369 
Propanolol (PROP) 83 
Sulfadiazine (SLF) 24 
Thrimethoprim (TMP) 177 
Phenozenone (PHN) 21 
Tramadolol (TRM) 986 
Iomeprol  3211 
Iopamidol 2484 
Citaloprom (CIT) 329 
Clarithromicin (CLR) 176 
Sulphametizole (SLM) 2543 
Venlafaxine (VEN) 331 
Ciprofloxacin (CIP) 12554 
Clindamicin (CLN) 19 
Erithromicin (ERT) 176 
Triclosan (TRC) 18739 
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3.2.2 The removal of pharmaceuticals as XOCs 
The observed removal efficiencies of pharmaceuticals were estimated using influent 
and reactor concentrations as described in the introductory chapter. 
Assuming that perfect mixing conditions are established, the concentrations in S3 and 
U are equal to the concentrations in the effluent of staged and unstaged 
configurations. Whenever it was possible the results of the calculations are averaged 
on the 6 days of sampling. For pharmaceuticals with concentrations below LOQ and/or 
LOD, a range of removal efficiencies could be estimated. concentration of ATE and 
PROP are not quantified. The efficiency for DCF, VEN, CBZ and SMX was calculated on 
4, 3, 2 and 1 set of samples, respectively, due to low accuracy in the quantification 
procedure.  
Table 3-7 shows maximum, minimum and mean concentrations in the influent and in 
the two final effluents. The applied error in the measurement is the standard 
deviation. With regard to SLF, error is the sensibility of the instrument (10%) because 
we considered only one set of sample. Observed removal efficiencies reported in 
literature are also listed in the table 9. 
We observe: 
 high degradation in the cases of ATE e PROP; 
 average degradation for TMP e CIT; 
 no degradation for DCF; 
 negative degradation for SMX and SFM. 
A negative removal was shown for SMX possibly because of the intense 
retransformation of its major metabolite N4-Acetyl-sulfamethoxazole (N4-Ac-SMX) to 
SSMX. N4-Ac-SMX is the major conjugated metabolite excreted after SMX 
administration, being detected at approximately 3-fold higher concentrations in urine 
as compared to parent SMX. The conjugated acetyl group is readily cleaved  and the 
removal of N4-Ac-SMX is usually complete (Ternes and Joss, 2006).  
Based on the results found for beta-blockers (MTP, PROP, ATE), a specific discussion 
was considered for these substances.  
  
61 
 
 
Table 3-5 Concentrations of pharmaceutical in the feeding medium and in the effluents (ng/L); and observed removal efficiency (%); 
Compound Influent (ng/L) Effluent (ng/L) Removal efficiency (%) 
UNSTAGED STAGED observed  Literature (**) 
Maximum Minimum Average / St.Dev. Maximum Minimum Average  Maximum Minimum Average  UNSTAGED STAGED   
Atenolol (ATE) 395.95 340.54 360.81 / 30.54 <LOQ <LOD   <LOQ <LOD     14.4% - 46% 
Propanolol (PROP) 88.38 79.19 83.04 / 4.77 <LOQ  <LOQ   <LOQ  <LOQ    05 - 1% 
Metoprolol (MTP) 1526.35 1365.54 1441.21 / 81.82 1472.30 1205.41 1327.03 / 91.12 1181.76 1533.11 1381.08 / 124.38 7.92% 4.17% 6.50% 
Sulfamethoxazole (SMX) 173.92 98.58 141.10 / 38.59 272.09 225.74 264.45 / 41.93 345.27 254.73 282.13 / 32.94 -87.42% -99.95% 17.30% 
Trimethoprim (TMP) 205.68 142.23 176.69 / 32.07 121.01 60.34 95.89 / 19.89 163.38 59.53 117.53 / 36.07 45.73% 33.48% 5.10% 
Citalopram (CIT) 340.54 308.78 329.28 / 17.77 165.95 113.92 132.92 / 19.09 171.89 84.46 126.23 / 30.75 59.63% 61.66% 27% 
Diclofenac (DCF) 320 268 292.79 / 26.42 289.19 235.14 273.63 / 21.93 297.30 230.14 272.39 /29.71 7.00% 6.97% 5% 
Carbamazepine (CBZ) 173 128 143.56 / 25.73 150.00 115.41 133.83 / 12.45 109.59 109.59 109.59 / 10.96 6.78% 23.66% 5.8% - 9.5% 
Sulfamethizole (SLM) 2861 2257 2542.79 / 303.29 2800.68 2256.76 2542.79 / 303.29 2004.73 2004.73 2004.73 / 200.47 0.69% 11.17% 17.30% 
Venlafaxine (VEN) 356 312 331.53 / 22.41 318.92 288.51 304.28 / 14.27 319.59 263.04 286.55 / 29.45 8.22% 13.57% 19% 
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Fig.12 compares the observed removal in the system and data from the literature for 7 over 10 
investigated chemicals. The removals of CBZ and SLF in the staged reactor are not discussed 
because only one set of sample was available. SMX has negative removal and it does not appear 
in the plot, it is discussed separately. 
We observed that CIT and TMP are highly removed in both configurations of the system, more 
than twice the removal from the literature. The observed removal of DCF, CBZ and MTP are 
consistent with data from the literature. While VEN in the system is less removed; the ratio is 
almost 0.75 for the unstaged and 0.5 for the staged. 
Fig.12 shows also that the removal rates for VEN, DCF, CBZ  and MTP range from less 6% to 20%, 
while only TMP and CTL have high removal rate (>30% and ≈60%). 
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Figure 3-8 ΔXOCs (%) observed and from the from the literature; 
The case of Β-blockers 
The concentration of ATE was found to be lower than LOQ in the effluent from the unstaged and 
it is lower than LOD in the staged reactor. The concentrations of PROP in the effluents are also 
lower than the LOQ. Assuming the respective LOD and LOQ as final concentrations from the 
systems and considering the average concentrations in the influents, we estimated that the 
unstaged and the staged configuration have removal up to 91% for the Atenolol and up to 23.5% 
for PROP. While for MET we observed lower removal; 7.93% in the unstaged and 4.17% in the 
staged. 
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The β-blockers have similar chemical structure and consequently they would be expected to 
show similar removal. Data on degradability of these chemicals are inconsistent also in the 
literature; the range of variation is wide, from 10% to 96% ( (M.Maurer, B.I. Escher, P.Richle, C. 
Schaffner, A.C. Alder, 2007). 
ATE and PROP have concentration lower than LOQ in S2 and S3, thus discussions about the 
progressive elimination from S1 to S3 was not possible. 
Regarding with the first two days of screening, we observed that MET is more eliminated in the 
staged reactors, Figure 13. The elimination occurs in S3 and minority in S2, the last two stages 
seems to be responsible for the higher performance. According to the research hypothesis, after 
an adaptation period the bacterial communities in S1, S2 and S3 somehow differentiate and 
specialize to the specific conditions in each reactor. The differentiation may result in different 
metabolism and eventually higher degradation of XOCs in S3 and S2 where the easy 
biodegradable substrate is less available. The observation on the first two days of screening 
would confirm the hypothesis.  
However the measurements in the last 4 days do not agree completely. We suppose that the 
adaptation period is not completed yet and the different efficiencies between the reactors may 
not be remarkable yet.  
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Figure 3-9 Metoprolol removal in staged and unstaged reactors 
The hypothesis of enhanced removal of pharmaceuticals has been confirmed only for a limited 
number of pharmaceuticals. However, it should be noted that the number of samples 
considered in the study 
By now the analysis on the continuous flow experiment do not confirm the hypothesis. Later in 
the chapter, the same is discussed considering the results of the batch experiments. Other tools, 
e.g. microbiological analysis, could further elucidate on whether any differentiation in the 
bacterial communities, with respect to metabolism of pharmaceuticals occurred for the reactor 
biomass  
64 
 
 
3.3 The biomass 
The cultivated carriers have been collected from the postdenitrification reactor configuration in 
Sjolunda WWTP in Sweden. The reactor is divided in 2 zones and methanol is supplied in the first 
zone. The supply of carbon is estimated to be completely utilized in the first zone, consequently 
the biomass in the second zone is carbon limited. We preferred to sample from the second zone 
in order to make the “transition” to our system as easy and fast as possible. We expected to 
observe an adaptation period in any case. However since the biomass is also carbon limited, this 
period may be shorter than in the case of biomass from the first zone where the methanol is 
supplied. 
Fig. 14 shows the variation of biomass concentration (gTSS/L) from the beginning of the 
experiment until the day after the batch experiment. We observe that in this period the biomass 
grew differently in the reactors. Particularly we notice very high concentration in S1 where the 
sCOD is abundant. On the contrary in S2, S3 and U the availability of organic source sometimes 
has been limiting for the process; in these reactors the biomass content is lower and the 
observed values are similar. 
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Figure 3-10 variation of the biomass concentration since the first day of operation, (gTSS/L). 
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Figure 3-11 AnoxKaldnes K1 from Unstage reactor 
 
Figure 3-12 AnoxKalnes K1 from S1 
 
Figure 3-13 AnoxKalnes K1 from S2 
 
Figure 3-14 AnoxKaldnes K1 from S2 
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4 The batch experiments – results & discussion 
4.1 Characterization of the feeding medium 
The fractionation of the feeding medium for the batch experiment has been quantified by the 
same procedure applied in the continuous flow experiment for the characterization of the 
medium (par. 3.1). 
Table 4-1 COD fractionation of the batch medium 
fraction Concentration (mgCOD/L) 
Total COD 540 
sCOD 120 
bCOD 237.2 
Xs 139.2 
XI 280.8 
SI 21.6 
 
4.2 Biomass 
4.3 The primary metabolism 
By monitoring the utilization of primary substrates during the batch experiments, we aimed at 
comparing biokinetics in each reactors and explain their behaviour during continuous operation. 
In this paragraph we first discuss the utilization curves of the substrate on a qualitative base, 
then we estimate the growth yield (Yh) and the maximum growth rate. On these estimations we 
discuss and compare the metabolism of the bacterial communities in each reactor. 
As introduced in par. 2.2.1, there are three different fractions of COD capable of supply the 
electrons required for denitrification, (Henze M. et al., 2008):  
 the ready biodegradable fraction of bCOD in the medium (Ss); 
 the slowly biodegradable fraction of bCOD in the medium (Xs); 
 the slowly biodegradable organics generated by death and decay of the biomass(Xs,BH). 
The availability and the utilization of these fractions are different and they affect the rate of 
denitrification (rD) and thus the slope in the nitrate concentration curves. Two or three phases 
are defined by observing changes in the denitrification rates, where in the first case no 
distinction between utilization of Xs and Xs,BH is considered. , (Henze M. et al., 2008) (K.kujawa 
and B.Klapwijk, 1998). The rates (rD ) are defined as in par. 2.2.1. 
Due to biomass detachment observed during the experiment, the extent hydrolysis of Xs and 
Xs,BH could not be quantified. Additionally, no storage of Ss in the biomass was considered.  
Because of the stoichiometric proportion between the electron donor and the electron acceptor 
in the process, we estimated the differentiation in phases on the observed utilization of NO3,2-N. 
Then considering the relative time period, we “assumed” the same phases also for the utilization 
of sCOD. Fig. 15 shows the separation between 1st and 2nd phase, where the Ss fraction in the 
feeding medium is assumed to be completely consumed. 
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By preliminary observations on the reduction of sCOD in the reactors we notice that the 
unstaged and the three stages perform differently. We also notice that in U (fig. 15a), S1 
(fig.15b), S2 (fig.c) the 1st phase deducted from the NO3-N curves agree with the variation of 
sCOD concentration over time, while in S3 (fig.15c) it does not. 
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Figure 4-1 concentration of sCOD (mgCOD/L) over time. 
On the other hand the mass balance of sCOD (and so the sCOD observed removal) account for 
three different processes, these are: the hydrolysis, the storage and the consumption itself. They 
occur simultaneously and they are opposite. Again since we ignore the rates of each process, the 
observed removal of sCOD probably underestimates the actual consumption. 
However the relevance of hydrolysis in the sCOD balance is evident in the case of S3, fig. 15b. As 
well as in the other reactors, probably denitrification is also intense in the 1st phase (1.6 hours), 
but we do not observe fast utilization of sCOD. Probably the hydrolysis is more intense than in 
the other cases; this may affect the balance and so the observed removal of sCOD is lower (the 
slope in the utilization curve is less steep).  
Again we supposed that this is because of some adaptation occurred during the continuous flow 
experiment. In the three months during the continuous flow experiment the source of organics 
in S3 has been limiting the optimum metabolism; the available fraction in the medium consists 
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of X2 and Xs,BH because of the utilization in S1 and S2. Eventually the bacteria community 
developed some affinity to the form of the substrate and a faster hydrolysis.  
Fig.16 shows the utilization of nitrates and nitrites within the 24 hours of the batch experiment, 
by the dashed red line we approximately distinguish the first phase from the second one.  
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Figure 4-2 Concentrations of NO3-N and NO2-N over time in the four batch reactors. 
In fig. 16 we also observe that nitrites concentrations increase during the first phase, this 
temporary accumulation is due to a “less energetically convenient” red-ox reaction. Since the 
reduction of nitrate provides more energy (2 electrons) than the reduction of nitrite (1 
electrons), nitrates are “the favorite” substrate compared to the other nitrogen specie.  
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Fig. 17 shows the removal of NO3-N (mg NO3-N/L) normalized on the amount of biomass (gTSS/L) 
in each reactor. The concentration of TSS has been measured after the batch experiment; we 
supposed that the growth of biomass within the period of the experiment is negligible. The 
procedure for the quantification is the same that we applied for the continuous flow experiment 
(appendix C).  
Within the 24 hours of the experiment, the four reactors achieve similar removal of nitrates per 
amount of biomass (≈20 mgNO3-N/gTSS). 
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Figure 4-3 removal of NO3-N (mg NO3-N/gTSS) over time in the unstaged and in the staged configuration 
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4.3.1 Estimation of biokinetic parameters 
The three phases 
In S3 we did not observe the endogenuous phase; the entire period is divided in two phases 
only. 
By the amount of biomass in each reactor and assuming that the bacteria growth is negligible in 
24 hours, we estimate the specific rates (tab. 5). 
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Figure 4-4 three phases in the unstaged reactor 
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Figure 4-5 three phases in the S1 
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(c) S2
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Figure 4-6 three phases in the S2 
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Figure 4-7 two phases in S3 
Table 4-2 utilization rates (Lh/mgNO3,2-N)  
Reactor  rD1  
(mgNO3,2-N/Lh) 
rD2 
(mgNO3,2-N/Lh) 
rDS 
(mgNO3,2-N/Lh) 
rD3 
(mgNO3,2-N/Lh) 
Unstaged 12.47 1.6 10.87 0.15 
S1 17.52 2.18 15.34 1.30 
S2 18.59 1.89 16.7 0.95 
S3 23.49 0.44 23.05  
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Table 4-3 specific utilization rates (mgNO3,2-N/mgCOD*d) 
Reactor  Xbh 
(mgCOD/L) 
k1 
(mgNO3,2-
N/mgCOD*d) 
k2 
(mgNO3,2-
N/mgCOD*d) 
kDS 
(mgNO3,2-
N/mgCOD*d) 
k3 
(mgNO3,2-
N/mgCOD*d) 
Unstaged 2393.33 0.125048 2393.33 0.125048 2393.33 
S1 4068.89 0.10334 4068.89 0.10334 4068.89 
S2 2414.11 0.184813 2414.11 0.184813 2414.11 
S3 2262.22 0.249207 2262.22 0.249207 2262.22 
 
The four reactors have similar observed removal of NO3,2-N per gramm of biomass (fig.17) but 
different utilization rates (tab. 5). 
With regard to the 1st phase, k1 is maximum in the S3 and minimum in the S1. While the amount 
of ΔNO3,2-N is approximately 65 mgNO3,2-N/L in S1, S2 and S3 and 70 mgNO3,2-N/L. The duration 
of the 1st phase is minimum in S1 and maximum in the unstaged reactor.  
The specific rates in the 2nd phase are similar in U, S1 and S2, but not in S3. S3 has the smallest k, 
its 2nd phase last more than 22.5-23 hours and we do not observe any significant change in the 
slope to distinguish S2 and S3 during the time of the batch experiment. 
S1, S2 and U reach the endogenous phase almost at the same time, approximately after 16 
hours. 
The previous observations disagree with what expected. Despite of the unstaged and S1 are 
feeded with media close to that one in the continuous flow experiment and they are supposed 
to be used to the abundance of Ss, S3 and S2 perform at higher or similar rates in the 1st phase 
and lower rate in the 2nd phase.  
 
Growth yield (YH) and the maximum growth rates (μh,max) 
YH and μH are estimated according to the methodology in par. 3.2.1. Except for nitrite, we 
ignored if the other intermediates accumulated during the batch experiment, therefore for most 
of the experiments it was not possible to know whether complete denitrification actually 
occurred.  
We estimate the growth yield (YH) and the maximum growth rates (μH) in four different 
scenarios:  
1. nitric oxide (NO) as terminal electron acceptor; 
2. nitrous oxide(N2O) as terminal electron acceptor; 
3. Nitrogen gas (N2) as terminal electron acceptor, i.e. complete denitrification. 
The calculations based on the following assumptions: 
 within the first and the second phase the bCOD fraction (Ss+Xs) in the feeding medium is 
completely utilized; 
 Ss>> Ks and the Monod kinetic is further simplified. 
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Table 4-4 growth yield, YH (mgNO3,2-N/L) 
Reactor estimate ΔNO3,2-N 
(mgNO3,2-N/L) 
assumed ΔsCOD 
(mgΔsCOD/L) 
Yh2 
(to NO) 
Yh3 
(to N2O) 
Yh4 
(complete den.) 
Unstaged 54 237.25 0.609 0.479 0.349 
S1 51 237.25 0.631 0.631 0.385 
S2 48.586 237.25 0.649 0.649 0.414 
S3 34.24 237.25 0.752 0.752 0.587 
 
Table 4-5 maximum growth rate, μH,max (mgCOD/mgCOD*d) 
Reactor μh2 
(mgCOD/mgCOD*d) 
μh3 
(mgCOD/mgCOD*d) 
μh4 
(mgCOD/mgCOD*d) 
Unstaged 1.32 1.26 1.38 
S1 1.12 1.12 1.10 
S2 2.03 2.03 1.91 
S3 3.88 3.88 2.99 
 
Despite of that the observed substrates utilization is maximum in U and minimum in S3, S3 is the 
reactor with the highest values for Yh and μh in the four scenarios. This could be interepreted as 
evidence of a more efficient metabolism: even if less substrate is consumed the synthesis of new 
biomass per amount of sCOD oxidized is larger and faster. On the contrary both U and S1 show 
the lower values for Yh and μh in each of the scenarios 
The estimated values μh,max of referred to the 1
st phase in the batch experiment, where the Ss is 
available. While during the continuous flow experiment the media in S2 and S3 are supposed to 
be partially and completely depleted of ready biodegradable substrate. Indeed the observed 
growth rate  in S3 in the entire period is the lowest 
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5 Conclusion 
This study suggests the potential benefit of staging MBBR reactors as optimization of 
denitrification process under anoxic conditions, confirming the hypothesis made. The staged 
configuration ensured higher conversion of influent NO3-N, using non-synthetic wastewater 
feed. Under equal operating conditions (i.e. the same operational volume) higher performance 
was achieved in the staged configuration possibly as a result of biomass adaptation to the 
different feeding conditions, both in terms initial influent (S1) and the influent to the further 
stages (S2, S3). This further suggests that reactor staging could ensure reaching comparable 
performances in terms of nitrate removal using a reduced overall reactor volume, as compared 
to the unstaged configuration. 
It can be concluded that the staged reactor seemed to be more robust during the period of 
evaluation. S2 and S3 ensured almost constant denitrification efficiencies regardless of the 
quality of the medium. On the other hand, S1 and U performances were strongly affected by 
influent quality in terms of content of bCOD and Ss. The continuous operation of S2 and S3 under 
carbon-limiteing conditions led to adaptation of biomass to denitrification using hydrolysis 
products of slowly biodegradable substrate. Further investigations, e.g., microbiological analysis 
and complete COD fractionation in the same reactors, are required to confirm this hypothesis. 
Among the pharmaceuticals assessed, the highest removal efficiency (>40%) in the tested 
conditions was shown for the beta-blockers atenolol and propranolol, the antidepressant 
citalopram and the antibiotic trimethoprim. For a number of other substances (), removal 
efficiency did not exceed 10%. For sulfamethoxazole, retransformation of the major metabolite 
(N4-acetyl-sulfamethoxazole) lead to negative removal efficiencies (< -100%) No definitive 
conclusion on which MBBR configuration performed better in terms of pharmaceuticals removal 
was reached. Promising results, satisfying the initial hypothesis of improved removal in the 
staged configuration, were shown for metoprolol. 
 Batch experiment allowed to estimate biological kinetics for denitrification in the different 
MBBR reactors under the same feeding conditions. Different behaviour shown by the variations 
in specific denitrification rates and by the estimated biokinetic parameters (heterotrophic yield 
Yh and maximum heterotrophic growth rate coefficient µH,max) seem to suggest an adaptation of 
the bacterial community during the three months of continuous operation.The specific 
denitrification rate per unit biomass during the 1st phase of denitrification  (utilizing the non-
limiting Ss fraction in the feed) increased from reactors S1 to S3. Two possible explanations exist: 
 Utilization of feeding Ss for denitrification does not require any biomass adaptation ; 
 Hydrolysis in S2 and S3 was important under batch experimental conditions and may 
have affected denitrification in the 1st phase identified and, if performed at higher rates 
as compared to S1, could have provided for additional Ss immediately available as 
electron donor for denitrification. 
With regard to the utilization of pharmaceuticals, observed removal under continuous operation 
was consistent with data available in the literature. Preliminary observations on the results from 
the batch experiment agreed with this observation and seemed to describe removals obtained 
under conitunuous operation for atenolol, sulfametoxazole, trimethoprim, carbamazepine and 
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Dicofenac. It can be concluded that three months of operation may have not been sufficient for 
adaptation to drive the evolution of the bacteria communities to the consumption of XOCs.  
The different growth experienced during the continuous flow experiment and the different 
metabolic kinetics extracted from the batch experiment confirm that the bacterial community 
adapted to the specific conditions in each reactors. Eventually by further microbiological analysis 
we could assess more precisely how the biodiversity changes and how it evolves over time. 
Furthermore, if the expression of enzymes specifically involved in denitrification and in the 
degradation of XOCs is established, we could assess more precisely the intensity of 
denitrification itself and how much the bacteria evolve towards the consumption of XOCs in 
each reactor. 
In accordance to the observations on the primary metabolism, this study confirms the validity of 
staging even in for MBBR. By the adaption of the biomass to the specific conditions in the stages, 
staged MBBR achieves better performances for the removal of NO3-N. Further investigation on 
different configuration and on a longer monitoring period are still required to establish the 
convenience of this solution to remove XOCs in wastewater. 
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Appendix A – The Anaerobic Aromatic Metabolism 
Next to carbohydrates, aromatic compounds are the second most abundant class of organics 
(Boll M., 2004). This category includes a large variety of different substances that are ubiquitous 
growth substrates (Harwood C.S., Burchhardt G., herrmann H. and fuchs G., 1999). Since the 
aromatic ring has resonance energy higher than 100 kJ/mole, the aromatics are usually inert and 
difficult to be biodegraded (Boll M., 2004). But it has been proven that major types of anaerobic 
heterotrophs bacteria, acetogenic bacteria and fungi can consume them also in absence of 
oxygen (Heider J. and Fuchs G., 1996) (Gibson J. and Harwood C., 2002). In anoxic environments 
oxygenases is repressed and the all oxidative enzymatic processes involving oxygen are replaced 
by alternative reductive pathways (Boll M., 2004) (Philip B. and Shink B., 2012). The strategy of 
anaerobic bacteria is to convert low-molecular weight aromatic substrates by peripheral 
pathways into few key intermediates. The most probable intermediates are: Benzoyl-CoA 
(BCoA), phloroglucinol, hydroxyquinone and resorcinol (Boll M., 2004). Then the intermediates 
are further degraded by central pathways (Fuchs G., Mohamed M. E., Altenschmidt U., Koch J. 
Lack A., Brackmann R. Lochmeyer C. and Oswald B., 1994). The pathways in anoxic conditions 
rely on reductive biochemistry, and they include carboxilations, reductive dehydroxilations and 
addition reactions (Heider J. and Fuchs G., 1996). In anaerobic bacteria, most aromatic growth 
substrates are channelled into the BCoA degradation pathway (G. Fuchs, M. Boll and J. Heider, 
2011) (Heider J. and Fuchs G., 1996) (Gibson J. and Harwood C., 2002) (K. Kuntze, Y. Shinoda, H. 
Mouttaki, M. J. McInerney, C. Vogt, H.Richnow and M. Boll, 2008).  
So BCoA emerges as the most common intermediate and a broad variety of aromatic molecules 
enter this pathway, such as  halogenated molecules, methoxylated molecules or compounds 
having a carbon side chains (Gibson J. and Harwood C., 2002) (Philip B. and Shink B., 2012). In 
this pathway the aromatic ring is reduced and cleaved to acetyl-CoA and CO2 (Heider J. and 
Fuchs G., 1996) (Gibson J. and Harwood C., 2002). The complete degradation produces one mole 
of CO2 and three moles of acetyl-CoA, which are further oxidised via the citric cycle, via the 
oxidative acetyl/carbon monoxide dehydrogenase pathway or via the reductive carboxylation to 
pyruvate. The BCoA pathway consists of the following four steps, fig 3 (K. Kuntze, Y. Shinoda, H. 
Mouttaki, M. J. McInerney, C. Vogt, H.Richnow and M. Boll, 2008) (Heider J. and Fuchs G., 1996) 
(Simon Wischgoll, Martin Taubert, Franziska Peters, Nico Jehmlich, Martin von Bergen and 
Matthias Boll, 2009): 
I. Reductive dearomatization of BCoA to cyclohexa-1,5-diene-1-carbonyl-CoA catalysed by 
BCoA reductase (BCR); 
II. Water addition to cyclohexa-1,5-diene-1-carbonyl-CoA forming 6-hydroycyclohex-1-ene-
1-carbonyl-CoA catalysed by dienoyl-CoA hydratase; 
III. Oxidation of the forming 6-hydroycyclohex-1-ene-1-carbonyl-CoA  to 6-oxocyclohex-1-
ene-1-carbonyl-CoA (6-OCH-CoA) by an alcohol hydrogenase; 
IV. Hydrolityc ring cleavage and addition of water molecule yielding 6-hydroxypimelyl-CoA 
catalysed by ring opening hydrolase (6-OCH-CoA hydrolase).  
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Figur 1 Initial steps of BCoA pathway in Thauera aromatic (A) and Rhodopseudomonas palustris (B) (Simon 
Wischgoll, Martin Taubert, Franziska Peters, Nico Jehmlich, Martin von Bergen and Matthias Boll, 2009) 
The BCR is recognized as the central enzyme in the “aromatic metabolism”. In the past many 
investigations targeted it as it was supposed to picture the bacterial community degrading 
aromatic compounds. The synthesis of BCR has been detected in many denitrifying bacteria both 
from pure cultures and environmental samples (Harwood C.S., Burchhardt G., herrmann H. and 
fuchs G., 1999) (Gibson J. and Harwood C., 2002) (B. Song and B. B. Ward, 2005). So far two 
types of BCR have been found; bzd type from Azoarcus and bcr type from Thauera (K.Kuntze, C. 
Vogt, H.H. Richnow and matthias Boll, 2011). Since the amino acid sequences are very different, 
they are very specific for each enzyme (K. Kuntze, Y. Shinoda, H. Mouttaki, M. J. McInerney, C. 
Vogt, H.Richnow and M. Boll, 2008). Primers for both reductases have been isolated and by gene 
amplification we manage to: detect the different types of BCR, determine the dominant and/or 
the activated ones in particular conditions and also identify and differentiate bacteria within the 
whole community (K. Kuntze, Y. Shinoda, H. Mouttaki, M. J. McInerney, C. Vogt, H.Richnow and 
M. Boll, 2008) (B. Song and B. B. Ward, 2005) (Breese K., Boll M., Alt-Morbe Juliane, Schagger H. 
and Fuchs G., 1998).  
But the divergence between the BCRs-genes makes impossible to establish the design of good 
degenerate primer to detect both types of enzymes and to monitor the whole bacterial 
community (B. Song and B. B. Ward, 2005) (K. Kuntze, Y. Shinoda, H. Mouttaki, M. J. McInerney, 
C. Vogt, H.Richnow and M. Boll, 2008). Furthermore some false-positive results have also been 
detected (Hosooda A., Kasai Y., Hamamura N., Takahata Y. and Watanabe K., 2005). In the end 
BCR is not reliable to investigate the whole bacterial community degrading aromatic 
compounds. 
In contrast to the BCR which differs among the denitrifying species (Fuchs G., Mohamed M. E., 
Altenschmidt U., Koch J. Lack A., Brackmann R. Lochmeyer C. and Oswald B., 1994), the genes 
encoding for 6-OCH-CoA hydrolase isolated in Thauera, Azoarcus and Magnetospirillum show 
high similarity (K. Kuntze, Y. Shinoda, H. Mouttaki, M. J. McInerney, C. Vogt, H.Richnow and M. 
Boll, 2008). The 6-OCH-CoA hydrolase is encoded by the bamA gene and its homologs oah and 
bzdY (A. W. Porter and L.Y. Young, 2013). Further investigations found that the bamA is highly 
conserved in all anaerobic bacteria using aromatic growth substrates. Since regions in bamA are 
highly conserved in different organism, it is an ideal candidate as biomarker for anaerobic 
aromatic hydrocarbon biodegradation (A. W. Porter and L.Y. Young, 2013) (K. Kuntze, Y. Shinoda, 
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H. Mouttaki, M. J. McInerney, C. Vogt, H.Richnow and M. Boll, 2008) (Y.N. Li, A.W. porter, A. 
Mumford, X.h. Zhao and L.Y.Young, 2011). A set of degenerate oligonucleotide gene primers for 
polymerase chain reaction (PCR) was also developed and successfully applied (K. Kuntze, Y. 
Shinoda, H. Mouttaki, M. J. McInerney, C. Vogt, H.Richnow and M. Boll, 2008) (A. W. Porter and 
L.Y. Young, 2013). Furthermore since the hydrolase is responsible for the cleavage of the 
aromatic ring, by looking at occurrence of 6-OCH-CoA hydrolase the whole “anaerobic aromatic 
metabolism” is targeted. 
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Appendix B – Wastewater characterization 
 
The series of data collected from the Oxitop heads have been fitted with the following 
exponential equation: 
           ; 
From the BOD curves we estimated the total BOD (BODtot) as the asymptotic value; 
         ; 
As S.R.Weijers (1999) prescribes, in order to determine the biodegradable COD fraction (bCOD) 
one more conversion factor have been applied. We considered the distance between the fitted 
curve and the asymptote by the following equation; 
            
 
         
⁄  
YH,BOD is not quantitevely motivated (S. R. Weijers, 1999), it varies between 0,1 and 0,2; we used 
YH,BOD = 0,1. 
As Roeleveld et al. (2002) prescribe and assuming that the biomass does not occur in the 
influent, on the previously defined analysis we determined the following carbon fractions: 
                    
             ; 
            
             (       )⁄         
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Appendix C – Protocols for the TSS measurement 
 
The measurement of TSS on the carriers has been repeated three times in each reactor, five non 
deformed carriers have been collected for the quantification. The procedure consists of: 
 Sampling of five non deformed carriers from each reactor; 
 Drying the carriers for 1.5 h at 103 °C; 
 Weighing the colonized carriers and recording the data; 
 Flushing the carriers with Sulphuric Acid (H2SO4) 4 M; 
 Shaking the carriers in solution of H2SO4 and water until the detachment of the biofilm 
starts; 
 Flushing the carriers with tap water; 
 Brushing the biomass out from the carriers and flushing again with tap water; 
 Drying the carriers for 15 min at 103 °C or in the essicator for 4-8 hours; 
 Weighing the empty and dried carriers. 
the TSS content is estimated by the following equation: 
                 [∑                         ∑        ] 
Considering the estimations from Anoxkaldnes about the carriers concentration per litre and on 
the knowing the amount of biomass per carrier, by the following equation we estimated the 
total biomass (Mtotalbiomass) and the biomass concentration (mbiomass) in each reactor: 
                                       
                              ⁄                  
Where f is the filling ration e Vreactor is the volume of the reactor. 
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Appendix D – Protocols for the analysis of 30 pharmaceuticals 
(HPLC-MS/MS) 
1. Sampling and storage 
 Sample: 10 mL sample with glass pipette in a 14mL glass vial. 
 Storage until reaching laboratory: 4°C and transport in a camping fridge 
 At the laboratory: add 3.5mL MeOH and store at -20°C until analysis. 
2. Sample preparation 
 Leave the stored samples to reach room temperature; 
 homogenize and transfer aprox. 1.5 mL to an HPLC vial;  
 Centrifuge the 1.5 mL vials 10 minutes at 6000 rpm;  
 With a syringe take 900 µl of the aqueous phase and transfer to a new HPLC vial;  
 Spike each sample with 100 µL of internal standard using syringe; 
 Between samples, rinse with 1mL MeOH and 1mL MiliQ water; 
 For the IS use the 100µL syringe meant for that IS solution. 
3. Internal Standard: 
 ac-sulfadiazine 13C6: 20 µg/mL, sulfadiazine 13C6: 14 µg/mL ibuprofen D3: 
118 µg/mL in MeOH;S 
Syringes: For the samples, use the 1mL “Samples” syringe.  
4. Analysis - HPLC-MS/MS 
The HPLC is a dual low-pressure mixing ternary-gradient system Ultimate 3000 from Dionex. The 
system is equipped with a pump of the 3000 series (DGP-3600 M), a 3000 TSL autosampler (WPS 
3000 TSL) and a column oven and degasser also from the Dionex 3000 series. The HPLC operates 
with two eight-port Valco valves. The mass spectrometer is an API 4000 (ABSciex, Framingham, 
MA, USA). The API 4000 operates in ESI in positive mode at 400°C with a capillary voltage of 
5500 V.The HPLC operates following gradient elution of methanol and Millipore water, both 
containing 0.2% formic acid (v/v) on a Synergi-Polar column (Phenomenex, Torrance, California, 
USA). All the assessment is based on the peak areas. A multilevel calibration is performed with 
four repeats each. 
Standard analysis: 10µL injection. Volumes up to 50µL can be injected. The obtained 
concentrations have to be corrected due to the initial MeOH addition. 
5. Standard curve preparation: 
 Stock solution containing 30 compounds in MeOH (Specified in another 
document); 
 Two intermediate stock solutions were prepared by adding 5 µL and 250 µL of 
the concentrated stock solution and filled them up with MeOH to 5 mL. 
 2 intermediate stock solutions were further diluted into the vials to the 
concentrations as shown in the table below with a methanol percentage of 36 
%. 
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 “0.1 ng/mL” “1 ng/mL” “2 ng/mL” “5 ng/mL” 
Intermediate Stock Solution added (1 µL/mL) [µL] 2.5 25 50 125 
Milli-Q H2O added [µL] 640 640 640 640 
Methanol added [µL] 257.5 235 210 135 
Internal Standard added [µL] 100 100 100 100 
 
 
“10 
ng/mL” 
“20 
ng/mL” 
“50 
ng/mL” 
“100 
ng/mL” 
“200 
ng/mL” 
Intermediate Stock Solution added (50 µL/mL) 
[µL] 
5 10 25 50 100 
Milli-Q H2O added [µL] 640 640 640 640 640 
Methanol added [µL] 255 250 235 210 160 
Internal Standard added [µL] 100 100 100 100 100 
 
6. Controls: 
For every batch, prepare 6 controls at the level of 50 ng/mL and spiked with the IS. 
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Appendix E – Protocol for the MBBR batch experiments 
 
After operation in continuous mode for approx. 3 months, staged and unstaged MBBR reactors 
will be operated in batch mode. Batch experiments with each reactor, containing MBBR carriers 
adapted to pre-clarified wastewater during continuous operation, are performed to assess 
denitrification kinetics and xenobiotics’ fate. 
Details on the operation during batch experiments: 
Reactor S1 (staged n. 1) S2 (staged n. 2) S3 (staged n. 3) U (unstaged) 
Volume 1.5 L 1.5 L 3 L 6 L 
Filling ratio  20% 20% 20% 20% 
Temperature 20°C 20°C 20°C 20°C 
Batch duration 24 h 24 h 24 h 24 h 
 
Reactors preparation 
 Stop continuous operation, disconnect reactors  
 Empty reactors from wastewater and carriers  
 Rinse/quickly wash reactors with water  
 Re-insert carriers the reactors, adjusting filling ratio to 20%. Keep extra carriers in flasks 
with wastewater, preserve at < 4° C.  
 Dose KNO3 in each reactor, reaching an initial concentration of 100 mg/L NO3-N in all 
reactors.  
 Fill all reactors with new wastewater inoculum.  
 Restart N2 sparging.  
 Fill aquarium with tap water, keep temperature around 20 C.  
 Insert one pH meter in each reactor.  
 Adjust pH in each reactor to 7.0 by adding HCl. 
When dosing is completed, the batch experiment starts (t=0).  
Operation 
 Temperature is controlled around 20°C by filling aquarium with tap water;  
 Temperature and pH in the reactors are continuously monitored using multimeters. 
 For each sample collected (=volume of wastewater removed), carriers are removed to 
keep the filling ratio (and biomass concentration) constant over the whole experiment. 
 Characterization of the wastewater inoculum is performed, determining initial 
concentrations of COD, sCOD, NH4, NO3 and xenobiotics. 
Sampling and analysis 
1. Initial sampling at t=0 from wastewater inoculum 
 Duplicates for COD, sCOD, NH4, NO3  
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 Triplicates for BOD 
 Duplicates/Triplicates for xenobiotics 
2. COD, sCOD, NO3, NO2  
 Volume of non-filtered sample to be collected = 3 mL  
 Volume of filtered sample = 10 mL  
 Total volume = 13 mL  
 For sample filtration, use 0.45 um siringe filters  
 Storage of samples at < 4° C  
3. Xenobiotics 
 Collect 4 mL of wastewater using glass pipette  
 Add 1.4 mL of MeOH (99% purity)  
 Storage of samples at -20° C  
4. BOD, NH4 
 Samples to be collected from each reactor at the end of the experiments (t=24 
h) 
5. TSS carriers 
 5 carriers are collected from each reactor at the end of the experiment (t=24 h) 
 Carriers in the oven at 105° C for > 1 h 
Details on sampling time, analytes and carriers removed for each sampling are included in the 
following table: 
Sampling time 
(min) 
Sampling 
time  
(h) 
Sample 
volume (mL) 
Sample 
collected for 
Carriers removed 
(carr./reactor) 
0 0 
From 
inoculum 
COD, sCOD, NO3, 
(NO2) 
NH4 
BOD 
Xenobiotics 
/ 
20 0.25 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
3 
40 0.5 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
3 
70 1 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
4 
100 1.5 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
3 
130 2 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
4 
180 3 13 
COD, sCOD, NO3, 
NO2 
3 
250 4 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
3 
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420 7 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
3 
600 10 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
4 
900 15 13 
COD, sCOD, NO3, 
NO2 
2 
1200 20 17 
COD, sCOD, NO3, 
NO2 
Xenobiotics 
4 
1440 24 13 
COD, sCOD, NO3, 
NO2 
NH4 
BOD 
TSS on carriers 
3 
 
  
89 
 
 
  
90 
 
 
Appendix F– the Continuous experiment MONITORING 
 
 NO2 concentration in the last 50 days of the operating period 
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 NH4 concentration in the last 25 days of the operating period
concentration influent and effluents
time (day)
10 15 20 25 30 35 40 45
m
g
N
H
4
-N
/L
10
20
30
40
50
60
70
80
time (day) vs influent 
time (day) vs effluent stage 
time (day) vs effluent unstage 
 
 
 Fluctuations of pH and temperature at the sampling time in the last 25 days 
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Appendix G –the Batch experiments DATA 
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Appendix H – linear regression NO3,2-N utilization curve 
Unstage 
linear Regression   Friday, March 28, 2014, 14:27:49 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9750 0.9507 0.9342  3.6495  
 
  Coefficient Std. Error t P  
 
y0 100.0000 2.4481 40.8472 <0.0001  
a -12.4722 1.4598 -8.5438 0.0034  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 35349.4953 17674.7476  
Residual 3 39.9562 13.3187  
Total 5 35389.4515 7077.8903  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 769.9040 769.9040 57.8060 0.0047  
Residual 3 39.9562 13.3187  
Total 4 809.8603 202.4651  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.5482) 
 
W Statistic= 0.9228 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(4) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 100}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -12.4722}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:29:10 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9367 0.8775 0.8366  3.3571  
 
  Coefficient Std. Error t P  
 
y0 70.1166 3.1118 22.5323 0.0002  
a -1.6027 0.3458 -4.6354 0.0189  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 16763.0523 8381.5262  
Residual 3 33.8098 11.2699  
Total 5 16796.8621 3359.3724  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 242.1507 242.1507 21.4865 0.0189  
Residual 3 33.8098 11.2699  
Total 4 275.9605 68.9901  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.1384) 
 
W Statistic= 0.8297 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(5) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 70.1166}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -1.6027}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:31:13 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.3787 0.1434 0.0000  2.3734  
 
  Coefficient Std. Error t P  
 
y0 46.3335 7.4517 6.2179 0.1015  
a -0.1522 0.3719 -0.4091 0.7528  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 5635.1430 2817.5715  
Residual 1 5.6333 5.6333  
Total 3 5640.7763 1880.2588  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 0.9430 0.9430 0.1674 0.7528  
Residual 1 5.6333 5.6333  
Total 2 6.5763 3.2881  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.1427) 
 
W Statistic= 0.8117 Significance Level = 0.0500 
 
Constant Variance Test  Failed (P = <0.0001) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(6) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 46.3335}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -0.152166}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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S1  
linear Regression   Friday, March 28, 2014, 14:22:31 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9856 0.9714 0.9619  2.5966  
 
  Coefficient Std. Error t P  
 
y0 100.0000 2.0113 49.7191 <0.0001  
a -17.5273 1.6422 -10.6730 0.0018  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 34324.0556 17162.0278  
Residual 3 20.2266 6.7422  
Total 5 34344.2822 6868.8564  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 687.6536 687.6536 101.9925 0.0021  
Residual 3 20.2266 6.7422  
Total 4 707.8802 176.9701  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.5936) 
 
W Statistic= 0.9296 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(8) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 100}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -17.5273}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:19:03 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9618 0.9251 0.9001  4.6058  
 
  Coefficient Std. Error t P  
 
y0 68.9430 3.4972 19.7139 0.0003  
a -2.5301 0.4156 -6.0876 0.0089  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 14170.2248 7085.1124  
Residual 3 63.6389 21.2130  
Total 5 14233.8637 2846.7727  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 786.1216 786.1216 37.0586 0.0089  
Residual 3 63.6389 21.2130  
Total 4 849.7605 212.4401  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.9326) 
 
W Statistic= 0.9796 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(9) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 68.943}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -2.53015}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:21:37 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.8846 0.7825 0.5651  4.3800  
 
  Coefficient Std. Error t P  
 
y0 49.3515 13.7516 3.5888 0.1730  
a -1.3020 0.6863 -1.8970 0.3088  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 1755.5291 877.7645  
Residual 1 19.1848 19.1848  
Total 3 1774.7139 591.5713  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 69.0368 69.0368 3.5985 0.3088  
Residual 1 19.1848 19.1848  
Total 2 88.2216 44.1108  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.1427) 
 
W Statistic= 0.8117 Significance Level = 0.0500 
 
Constant Variance Test  Failed (P = <0.0001) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(10) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 49.3515}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -1.30197}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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S2 
linear Regression   Friday, March 28, 2014, 14:32:39 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.8729 0.7619 0.6826  6.9985  
 
  Coefficient Std. Error t P  
 
y0 100.0000 4.5624 21.9181 0.0002  
a -18.5976 4.4262 -4.2017 0.0246  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 35301.4475 17650.7238  
Residual 3 146.9351 48.9784  
Total 5 35448.3826 7089.6765  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 470.2510 470.2510 9.6012 0.0534  
Residual 3 146.9351 48.9784  
Total 4 617.1861 154.2965  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.1467) 
 
W Statistic= 0.8331 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(12) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 100}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -18.5976}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:34:00 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9719 0.9446 0.9308  2.5384  
 
  Coefficient Std. Error t P  
 
y0 66.9826 1.8888 35.4632 <0.0001  
a -1.8897 0.2288 -8.2604 0.0012  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 17895.7134 8947.8567  
Residual 4 25.7731 6.4433  
Total 6 17921.4865 2986.9144  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 439.6506 439.6506 68.2340 0.0012  
Residual 4 25.7731 6.4433  
Total 5 465.4237 93.0847  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.2271) 
 
W Statistic= 0.8702 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0600) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(13) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 66.9826}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -1.88971}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:35:47 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9995 0.9991 0.9982  0.1834  
 
  Coefficient Std. Error t P  
 
y0 51.4140 0.5756 89.3154 0.0071  
a -0.9533 0.0287 -33.1796 0.0192  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 3233.1176 1616.5588  
Residual 1 0.0336 0.0336  
Total 3 3233.1512 1077.7171  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 37.0088 37.0088 1100.8857 0.0192  
Residual 1 0.0336 0.0336  
Total 2 37.0424 18.5212  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.1427) 
 
W Statistic= 0.8117 Significance Level = 0.0500 
 
Constant Variance Test  Failed (P = <0.0001) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(14) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 51.414}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -0.953261}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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S3  
linear Regression   Friday, March 28, 2014, 14:37:00 
 
Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.9125 0.8327 0.7770  5.8003  
 
  Coefficient Std. Error t P  
 
y0 100.0000 4.0659 24.5948 0.0001  
a -23.4954 4.8169 -4.8777 0.0165  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 34854.6269 17427.3135  
Residual 3 100.9295 33.6432  
Total 5 34955.5564 6991.1113  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 502.5242 502.5242 14.9369 0.0306  
Residual 3 100.9295 33.6432  
Total 4 603.4537 150.8634  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.7956) 
 
W Statistic= 0.9582 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(16) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 100}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -23.4954}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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linear Regression   Friday, March 28, 2014, 14:38:10 
 
S3 Data Source: NO3 in DELTA NO3 NEW 
Equation: Polynomial, Linear 
f = y0+a*x 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.6005 0.3606 0.1475  3.5614  
 
  Coefficient Std. Error t P  
 
y0 65.7608 3.0206 21.7707 0.0002  
a -0.4403 0.3385 -1.3008 0.2842  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression 2 19503.9931 9751.9966  
Residual 3 38.0498 12.6833  
Total 5 19542.0429 3908.4086  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression 1 21.4627 21.4627 1.6922 0.2842  
Residual 3 38.0498 12.6833  
Total 4 59.5125 14.8781  
 
Statistical Tests: 
 
Normality Test (Shapiro-Wilk)   Passed (P = 0.6117) 
 
W Statistic= 0.9322 Significance Level = 0.0500 
 
Constant Variance Test  Passed (P = 0.0500) 
 
Fit Equation Description: 
[Variables] 
x = col(2) 
y = col(17) 
reciprocal_y = 1/abs(y) 
reciprocal_ysquare = 1/y^2 
'Automatic Initial Parameter Estimate Functions 
F(q) = ape(x,y,1,0,1) 
[Parameters] 
y0 = F(0)[1] ''Auto {{previous: 65.7608}} {{MinRange: -12.3}} {{MaxRange: 36.9}} 
a = F(0)[2] ''Auto {{previous: -0.440276}} {{MinRange: -4.5}} {{MaxRange: 1.5}} 
[Equation] 
f = y0+a*x 
fit f to y 
''fit f to y with weight reciprocal_y 
''fit f to y with weight reciprocal_ysquare 
[Constraints] 
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Appendix I – utilization rate of pharmaceutical in the batch 
experiment 
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 Metoprolol 
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 Sulphametoxazole 
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 Carbamazepine 
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 Trimethoprim 
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 Diclofenac 
(a) unstaged
0.00
0.05
0.10
0.15
0.20
0.25
0.30
(a) S1
(c) S2
0 5 10 15 20
n
g
/g
C
O
D
0.00
0.05
0.10
0.15
0.20
0.25
0.30
(d) S3
time (h)
0 5 10 15 20
time (h)
n
g
/g
C
O
D
 
  
115 
 
 
  Sulphametizole 
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